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SUMMARY 
 
Molecular dynamics simulations were used to investigate the structural basis for 
the functions of three proteins: Fcγ receptor III (CD16), von Willebrand factor (VWF), 
and integrin. 
CD16, a heavily glycosylated protein expressed on human immune cells, plays a 
crucial role in immune defense by linking antibody-antigen complexes with cellular 
effector functions. Experimental data demonstrated that glycosylation of CD16 decreases 
its affinity for IgG. To understand the underlying structural basis, molecular dynamics 
(MD) simulations were performed for a CD16-IgG Fc complex with or without an N-
glycan attached in silico on residue Asn159 of CD16. The simulated complex structures 
show different conformations for the two forms of CD16, which induces changes in the 
IgG Fc binding pocket. Besides, CD16 itself was observed to transition between two 
conformations. In order to evaluate quantitatively the changes of CD16-IgG binding upon 
CD16 glycosylation, Molecular Mechanics-Poisson Boltzmann/Generalized Born Surface 
Area (MM-PB/GBSA) approach was applied to calculate the binding free energy of the 
two CD16-IgG Fc complexes. Although they gave opposite results for the total binding 
free energy due to large errors of solute entropy calculation, PB and GB methods 
predicted the same tendency of the changes of the effective energy, in which solute 
entropy part is excluded. According to the decomposition of the effective energy on each 
residue, the critical residues for CD16-IgG binding were identified and the changes of 
residue-residue interactions due to CD16 glycosylation were clarified. 
 xv
VWF, a multimeric multidomain glycoprotein, initiates platelet adhesion at sites 
of vascular injury. The three tandem A domains (A1, A2, and A3) of VWF play critical 
roles for its functions. The A1 and A3 domains contain respective binding sites for 
platelet glycoprotein Ib (GPIb) and collagen. The A2 domain hosts a proteolytic site for 
the VWF-cleavage enzyme A Disintegrin And Metalloprotease with a ThromboSpondin 
type 1 motifs 13 (ADAMTS-13). Previous studies suggested that shear flow or 
denaturants assists the ADAMTS-13 cleavage of VWF by unfolding the A2 domain and 
thus exposing the cryptic proteolytic site. Here steered MD (SMD) and free MD were 
used to simulate the unfolding of A1 and A2 by tensile force and under high temperature, 
respectively. The forced unfolding of A2 started from the C-terminus because of its 
specific topology. The β-strands of A2 were pulled out sequentially, generating sawtooth-
like peaks in the force-extension curves. The disulfide bond between A1 N- and C-
termini prevented it from being unfolded under low force. After eliminating the disulfide 
bond, A1 was unfolded similarly as A2 in terms of the β-strand pullouts, but differed in 
the unfolding of helices. The major resistance of A1 and A2 to unfolding came from the 
hydrogen bond networks of the central β-sheets. Two different unfolding pathways of the 
β-strands were observed, where the sliding pathway encountered much higher energy 
barrier than the unzipping pathway. The thermal unfolding of A1 and A2 was very 
different from the unfolding by tensile force. At 500K, A2 was unfolded from the C-
terminal portion, but A1 was unfolded from the N-terminal portion, reflecting their 
sequence variations and thus stability difference. 
Integrins mediate cell-cell, cell-extracellular matrix, and cell-pathogen adhesions 
essential in a wide variety of physiological and pathological processes. Experiments have 
 xvi
suggested that integrins undergo a large-scale global conformational change from a bent 
to an extended conformation upon activation. However, experiments show only static 
structures of integrins, and a complete understanding of the dynamic process of integrin 
conformational changes is still lacking. Here, SMD was applied to simulate in atomic 
details how integrins undergo structural transition from the bent to the extended 
conformation in response to tensile force. Homology models were first constructed for 
the unresolved I-EGF1/2 domain in the bent αVβ3 crystal structure to obtain a model of 
the complete ectodomain. Then, in an SMD simulation with a full, solvated integrin, a 
force was applied on the βA domain while the βTD domain was constrained to unbend 
integrin gradually without domain unfolding. A major force peak was observed, 
corresponding to the breakage of interactions at the Hybrid/EGF4 and Hybrid/βTD 
interfaces. Furthermore, free MD simulations were carried out to test stabilities of 
different conformations along the unbending pathway. Two partially extended 
conformations, existing immediately after the major force peak observed in SMD, were 
shown to be unstable and tended to bend back. One of them almost returned to the bent 
conformation. In contrast, two fully extended conformations was observed to be stable in 
free MD, their stabilities possibly due to the participation of residue Asp457 of the Thigh 
domain in the Ca2+ ion coordination at α-genu.  
In order to test whether leg separation affects the unbending of integrins as 
proposed by the switchblade model, SMD simulations were run to separate the two lower 
legs of the simulated αVβ3 integrin. A much larger force peak than that in the unbending 
simulations indicated that leg separation was much harder because of more extensive 
contacts between the two legs. After leg separation, more interactions were formed 
 xvii
between the headpiece and tailpiece of β-subunit. As a result, two additional force peaks 
were observed during the unbending with separated legs, showing more resistance. The 
free MD simulations for different conformations with separated legs showed contrary 
results to those with closed legs: a partially extended conformation did not return to its 
bent conformation and a fully extended conformation was not stable and bent back. 
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CHAPTER 1 
OBJECTIVES AND SPECIFIC AIMS 
 
 The overall objective of this thesis is to reveal structural basis by molecular 
dynamics simulations for the functions of three proteins: Fcγ receptor III (CD16), von 
Willebrand factor (VWF), and integrin. 
1. Study Structural Basis for the Glycosylation Effects on CD16-IgG Binding 
CD16-IgG binding acts as a linkage between the humoral and the cellular immune 
responses. Glycosylation of CD16 modulates CD16-IgG binding affinity and thus 
immune responses. It is unclear how the glycosylation of CD16 affects the CD16-IgG 
binding. To understand the structural basis for the glycosylation effects, first, molecular 
dynamics (MD) simulations were used to study the structures and dynamics of CD16-IgG 
complexes with or without CD16 glycosylation. Second, Molecular Mechanics-Poisson 
Boltzmann/Generalized Born Surface Area (MM-PB/GBSA) approach was utilized to 
calculate the binding free energy of CD16-IgG complexes and provide energetic 
information for CD16-IgG binding. 
2. Investigate the Unfolding Pathways of VWF A Domain under Tensile Force or 
High Temperature 
VWF A2 domain contains a cryptic proteolytic site for a plasma protease, A 
Disintegrin And Metalloprotease with a ThromboSpondin type 1 motifs 13 (ADAMTS-
13). Only after A2 unfolding, ADAMTS-13 can access the proteolytic site and cut 
ultralarge VWF (ULVWF) into short pieces to generate the full spectrum of circulating 
 2
plasma VWF species. To understand how ADAMTS-13 binds and cleaves the A2 domain, 
it is necessary to investigate how A2 is unfolded. First, steered molecular dynamics 
(SMD) was performed to simulate the unfolding of A2 by a tensile force, which is similar 
to the condition of shear flow in physiologic environment. As a comparison, the 
homologous A1 domain of VWF was also unfolded by SMD simulations. Second, MD 
simulations at 500 K were run to study the unfolding of A1 and A2 by thermal force, 
which mimic the unfolding by denaturants (e.g., urea) that was shown experimentally to 
increase ADAMTS-13 cleavage of VWF. 
3. Simulate the Unbending Process of αVβ3 Integrin Induced by Force 
Integrins mediate cell-cell, cell-extracellular matrix, and cell-pathogen adhesion 
and transmit signals bi-directionally across cell membranes. During signaling, integrins 
undergo a large-scale global conformational change from a bent to an extended 
conformation. To understand how integrin functions are regulated by its conformations, it 
requires studying the transitions between different conformations. Starting from a bent 
crystal structure of αVβ3 integrin, a complete ectodomain structure was obtained by 
building homology models of two unresolved domains. Then, SMD simulations were 
used to induce the unbending of αVβ3 integrin from the bent to the extended 
conformation. Stabilities of different conformations along the unbending pathway were 
tested. Furthermore, with separation of the legs of αVβ3 integrin that mimics inside-out 
signaling, the relation between extension and leg separation was studied. 
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CHAPTER 2 
BACKGROUND 
2.1 CD16-IgG Binding 
Roles of Fc Receptors in Immune Responses 
 
Figure 2.1 Functions of Fc receptors. Fc receptors expressed on immune cells connect antibody-
mediated humoral with cellular immune responses. Figure adapted from Sondermann et al. [1] 
 
 Fc receptors (FcRs) are membrane proteins expressed on immune competent cells. 
They play critical roles in an antibody-mediated immune response: Firstly, 
immunoglobulins (Igs or antibodies) circulating in blood recognize and bind antigens to 
form immune complexes; Secondly, these immune complexes are captured by FcRs on 
cell membranes; Thirdly, FcRs aggregate; Finnally, through intrinsic Immunoreceptor 
Tyrosine-based Activation Motif (ITAM) or Immunoreceptor Tyrosine-based Inhibitory 
Motif (ITIM) or associated ITAM containing polypeptides, FcRs trigger intracellular 
signaling cascades, resulting in stimulation or suppression of an immune response (Fig. 
2.1) [1]. 
 4
 Fcγ receptors (FcγRs) are one type of FcRs that specifically bind the Fc region of 
immunoglobulin G (IgG) [2]. FcγRs consist of three members: FcγRI, FcγRII, and 
FcγRIII. FcγRIII, also named CD16, is of interest in this thesis. 
CD16 Isotypes and Structures 
 
 
Figure 2.2 CD16 isotypes and structures. A. CD16 isotypes. Two Ig-like domains of each CD16 
molecule are depicted with N-glycosylation sites shown as sticks. Figure adapted from Chesla et al. [3] 
B. The CD16 crystal structure (pdb 1e4j). N- and C-termini are indicated. Disulfide bonds connecting 
two β sheets are shown as sticks. 
 
 CD16 includes two subtypes: CD16a and CD16b, which differ in their anchors on 
cell membranes (Fig. 2.2A) [3]. CD16a contains a transmembrane anchor, but CD16b has 
a glycosylphosphatidylinositol (GPI) anchor. Each CD16 molecule has two Ig-like 
domains (D1 and D2) with β sandwich folding (Fig. 2.2B), in which only six amino acids 
are different between CD16a and CD16b. Two major alleles of CD16b exist: NA1 and 
NA2, which differ by only four amino acids. CD16 is highly glycosylated with a 
molecular weight of 50-80 KDa. CD16a, CD16bNA1, and CD16bNA2 have 5, 4, and 6 N-
glycosylation sites, respectively. The glycosylation patterns are also cell type specific. 
NK cell CD16a but not monocyte CD16a was found to have high mannose-type 
oligosaccharides [4]. 
D1 
D2
Membrane
Intracellular
Extracellular 
N
C 
A B
D1 
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Figure 2.3 The crystal structure of a CD16bNA2-IgG Fc complex (pdb 1e4k). CD16bNA2 in green 
color, chain A of IgG Fc in red, and chain B in blue. Gray sticks represent saccharides on Fc. Pink 
spheres indicate N-glycosylation sites. 
 
The crystal structure of a CD16bNA2-IgG Fc complex shows that CD16 and IgG 
forms a 1:1 stoichiometric complex [5, 6]. The D2 domain and the D1/D2 hinge of CD16 
contact with the Cγ2 domains of IgG Fc. The Fc portion of IgG has an asymmetric 
opening upon binding, where Cγ2-B displaces more away from the symmetric axis of Fc 
than Cγ2-A. Two saccharide chains on Fc interact with each other and also have a few 
contacts with CD16. However, no saccharides on CD16 because the CD16 used for 
crystallization was produced in Escherichia coli. One of the six N-glycosylation sites of 
CD16bNA2, ASN159 (numbering according to Sondermann et al. [5]), locates right in the 
binding pocket, which most likely affect the CD16-IgG binding if glycosylated. 
Glycosylation Effects on CD16-IgG Binding 
 Different glycosylation patterns among CD16 isotypes or cell types result in 
varied affinities of CD16 to IgG. NK cell CD16a, which contains high mannose-type  
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Figure 2.4 2D affinities of CD16 to IgG measured by micropipette assay. CHO CD16 was treated 
or untreated with N-glycosylation inhibitor, Tunicamycin. Figure provided by Ning Jiang. 
 
oligosaccharide, has higher affinity to IgG than monocytes CD16a [4]. Ning Jiang’s 
experiments show that N-glycosylation of CD16 decreases its affinity to IgG by >10 
folds (Fig. 2.4, unpublished). Particularly, the N-glycosylation at residue ASN159 
contributed mostly to the decrease of CD16 affinity to IgG [7]. 
However, the structural basis of glycosylation effects on CD16-IgG binding is 
still not quite clear. The glycosylation at ASN159 could introduce a steric hinder to the 
CD16-IgG binding. But how it changes the binding in more details is not understandable 
with the structure of the unglycosylated CD16-IgG Fc complex. 
2.2 VWF A Domains 
Functions of VWF in Hemostasis 
von Willebrand factor (VWF) is a multidomain multimeric plasma glycoprotein 
that is synthesized and secreted by vascular endothelial cells and megakaryocytes [8, 9]. 
A major function of VWF multimers is to mediate the adhesion of platelets to 
subendothelial extracellular matrices at sites of vascular injury. When a blood vessel is 
injuried, subendothelial matrix containing collagen is exposed. VWF, which circulates in  
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Figure 2.5 Sequence of events in platelet-subendothelial interactions at a site of vascular injury. 
Platelets first tether to and roll on the subendothelium through GPIb-VWF interaction, followed by 
integrin-mediated firm adhesion and aggregation. Modified figure from Chen et al. [10] 
 
blood, binds to exposed collagen and is immobilized. Platelets then bind to immobilized 
VWF through GPIb receptors. GPIb-VWF interactions trigger intracellular signaling in 
platelets, which activate integrins α2β1 and αIIbβ3. Active α2β1 and αIIbβ3 interact 
with collagen and VWF, respectively, resulting in firm adhesion. Furthermore, platelets 
aggregate by αIIbβ3-fibrinogen interactions. Eventually, thrombus is formed to stop 
bleeding. (Fig. 2.5) [10] 
Structures of VWF and Its A Domains 
A VWF monomer consists of twelve domains: D1, D2, D’, D3, A1, A2, A3, D4, 
B, C1, C2, and CK from N-terminus to C-terminus (Fig. 2.6) [9]. Two monomers form a 
dimer through disulfide bonds between two CK domains. Then dimers are polymerized, 
by disulfide bonds connecting D3 domains, into large multimers with molecular weights 
of up to 20,000 kDa. The D’ and D3 domains bind to clotting factor VIII [11]. The C1 
domain contains a RGD sequence, which binds to αIIbβ3 integrin [12]. The A1 domain  
 8
Figure 2.6 Diagram of the VWF primary structure. Signal peptide (SP): residue 1 to 22, propetide: 
residue 23 to 763, and mature peptide: residue 764 to 2813. 
 
binds to platelet glycoprotein Ib (GPIb) [13, 14], collagen type VI [15], and heparin[16]. 
The A2 domain hosts a proteolytic site for a plasma protease [17], A Disintegrin And 
Metalloprotease with a ThromboSpondin type 1 motifs 13 (ADAMTS-13) [18], and the 
A3 domain contains a binding site for collagen type I or type III [19]. 
Each of the three tandem A domains in VWF (Fig. 2.7A) adopts a Rossmann fold 
with a central β-sheet flanked by α-helices as shown by the crystal structures [20-22] 
(Fig. 2.7 B and D). The central β-sheet consists of six β-strands (β1-β6) while the 
number of α-helices varies. The A1 domain contains six α-helices (α1, α3-α7) (Fig. 
2.7B). Compared to homologous integrin αM or αL αA domain [23, 24], the A1 domain 
lacks both the α2 helix and the metal ion-dependent adhesion site (MIDAS). Similarly, 
the A3 domain does not have the α2 helix and the MIDAS but has an α8 helix right after 
the α7 helix (Fig. 2.7D). A homology model [25] of the A2 domain shows that the α5 
helix becomes a loop and the proteolytic site on the β4 strand is completely buried (Fig. 
2.7C). The A1 and A3 domains contain disulfide bonds linking their N- and C-termini, 
which the A2 domain lacks. 
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Figure 2.7 Structures of the VWF A domains. A. Schematic of VWF tandem A domains. S-S 
represents a disulfide bond. The ADAMTS-13 proteolytic site, which locates at the peptide bond 
between Tyr1605 and Met1606, is indicated. B. Crystal structure of the A1 domain (pdb 1auq) [22]. 
α-helices are shown as coiled ribbons, β-strands as ribbons with arrows, and loops as tubes. Two 
spheres represent, respectively, the N- and C-terminal Cα atoms. The disulfide bond is indicated. The 
A1 domain consists of 6 α-helices (α1, α3-α7) and 6 β-strands (β1-β6). C. Homology model structure 
of the A2 domain [25]. The backbone atoms of Tyr1605 and Met1606 adjacent to the proteolytic site 
are shown as spheres in the middle. The A2 domain includes 5 α-helices (α1, α3, α4, α6, α7) and 6 
β-strands (β1-β6). α5 is a loop. D. Crystal structure of the A3 domain (pdb 1atz) [21]. The A1 domain 
has 7 α-helices (α1, α3-α8) and 6 β-strands (β1-β6). 
VWF Cleavage by ADAMTS-13 and Unfolding of A domains 
Upon stimulation, ultralarge VWF (ULVWF) multimers, which are stored in the 
Weibel-Palade bodies in endothelial cells or the α-granules in megakaryocytes, are 
secreted into blood [9, 26]. These ULVWF multimers bind GPIb more efficiently than 
plasma VWF [27]. ADAMTS-13 rapidly cleaves ULVWF on the endothelial surface [26, 
28] at the peptide bond between amino acid residues Tyr1605 and Met1606 in the A2 
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Figure 2.8 Model of VWF cleavage by ADAMTS-13. In blood flow, platelets bind to the A1 domain, 
generating tensile force. The force unfolds the A2 domain and exposes the proteolytic site for 
ADAMTS-13 cleavage. N: native state, I: intermediate state, and D: denatured state. Modified figure 
from Auton et al. [29] 
 
domain [17], which disassembles ULVWF multimers and creats the full spectrum of 
circulating plasma VWF species, ranging from a single dimer to about 20 dimers in a 
multimer [9, 26]. Dysfunction of ADAMTS-13 results in systemic microvascular 
thrombosis in thrombotic thrombocytopenia purpura (TTP) [18, 30]. Mutations in the A2 
domain, such as those in patients with type 2A von Willebrand disease (VWD), result in 
excessive proteolysis of VWF and thus the absence of high-molecular-weight VWF 
multimers, causing bleeding [31, 32].  
ULVWF multimers attached to the endothelial surface are under the shear stress 
of flowing blood and the tensile force of attached platelets, which assist the rapid 
proteolysis of ULVWF by ADAMTS-13 [26, 29]. Tsai et al. showed that the proteolysis 
of plasma VWF by ADAMTS-13, while does not occur under static conditions in vitro, 
was enhanced under shear flow [33]. Yago et al. found that ADAMTS-13 proteolysis of 
an A1A2A3 tridomain linking a microsphere to a platelet in the shear flow was increased 
by the shear rate [34]. Also, the addition of denaturants, such as urea and guanidinium 
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hydrochloride, increased the ADAMTS-13 proteolysis of plasma VWF [35, 36]. Why do 
shear flow and denaturants facilitate the proteolysis of VWF by ADAMTS-13? Auton et 
al. [29] proposed a model that tensile force might unfold the A2 domain and expose the 
proteolytic site, thus facilitate the proteolysis of VWF by ADAMTS-13 (Fig. 2.7). 
Therefore, it is of interest to study the unfolding mechanism of VWF A domains to 
understand the regulation of the proteolysis of VWF by ADAMTS-13. Experimentally, it 
is very difficult to study the dynamic processes of the unfolding of the VWF A domains 
in atomic details. In chapter 5, molecular dynamics (MD) was used to simulate the 
unfolding of the VWF A1 and A2 domains by tensile force or under high temperature. 
2.3 Integrins 
Integrin Functions and Structures 
Integrins are adhesion molecules that mediate cell-cell, cell-extracellular matrix 
(ECM), and cell-pathogen interactions [37]. They can regulate force-resistant adhesion, 
polarization in response to extracellular cues, and cell migration by integrating the 
cytoskeleton of cells with points of attachment in extracellular environments. Integrins 
are of vital importance to humans and many other organisms because they are related to 
important physiological processes such as tissue morphogenesis, inflammation, wound 
healing, and the regulation of cell growth and differentiation. 
An integrin molecule is a hetero-dimer consisting of two noncovalently 
associated, type I transmembrane glycoproteins: α- and β-subunits. To date, 18 α- and 8 
β-subunits have been identified in mammalia, forming 24 known integrins (Fig. 2.9A)  
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Figure 2.9 Integrin family and structure. A. Integrin family. In mammalian, 8 β and 18 α subunits 
form 24 distinct integrins. They can be considered in several subfamilies based on evolutionary 
relationships (coloring of α subunits), ligand specificity, and restricted expression on leukocytes. α 
subunits with gray hatching or stippling have inserted αA domains. Figure adapted from Hynes [38]. 
B. Domain organization in the primary structure of integrin. Asterisks show Mg2+ (blue) and Ca2+ (red) 
binding sites. Lines below the stick diagrams indicate disulfide bonds. C. Arrangement of domains 
within three-dimensional crystal structure of αVβ3 with an αA domain added. Figures B and C adapted 
from Takagi et al. [39] 
 
[38]. The α- and β-subunits contain respective extracellular domains of 940 and 640 
residues, single-span transmembrane domains, and short cytoplasmic domains of 20-50 
amino acids, except that β4 has a long cytoplasmic tail. The extracelluar domains form a 
globular headpiece that binds ligands and two long stalk legs that connect the headpiece 
to the transmembrane and the C-terminal cytoplasmic domains (Fig. 2.9C) [37, 39]. The 
α-subunit extracellular portion consists of a seven-bladed β-propeller domain (60 amino 
acids in each blade), a Thigh domain, and two Calf (1 and 2) domains. Nine α-subunits 
include an extra αA domain inserted between blades 2 and 3 of the β-propeller domain, 
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which adopts the Rossmann fold homologous to the VWF A domains. The β-subunit 
extracellular portion is composed of a PSI domain (named for plexins, semaphorins and 
integrins), a βA domain homologous to the αA domain, a Hybrid domain with a β-
sandwich fold, four cysteine-rich EGF domains, and a β-tail domain (βTD) (Fig. 2.9B) 
[37, 39]. 
Bi-directional Signaling of Integrins through Global Conformational Changes 
Integrins can transmit signals bi-directionally across the plasma membrane [40, 
41]. On one hand, ligand binding of integrins can be dynamically regulated through 
inside-out signaling, where stimuli received by cell surface receptors for chemokine, 
cytokines, and so on initiate intracellular signals that impinge on integrin cytoplasmic 
domains and alter binding affinity for extracellular ligands. On the other hand, integrins 
bound to soluble or immobilized physiologic ligands form clusters and transduce 
mechanochemical signals from the extracellular domain to the cytoplasm, which is called 
outside-in signaling.  
 During the bi-directional signaling, integrins undergo conformational changes that 
were revealed by a large amount of experimental data. The first crystal structure of the 
whole integrin ectodomain was solved for αVβ3 by Xiong et al. [42-44]. In the crystal, 
αVβ3 integrin adopts a bent conformation (Fig. 2.10A). The twelve domains of αVβ3 
assemble into an ovoid “head” and two “legs”.  The headpiece bends over the tailpiece to 
such an extent that it is extremely close to the C-terminal, membrane-proximal end of the 
two legs. In the headpiece of αVβ3 crystal structure, the angle between the Hybrid domain 
and the βA domain is acute, which is called the closed conformation. Recent published 
αVβ3 integrin crystal structure also showed the same bent conformation with a closed  
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Figure 2.10 Integrin crystal structures and 2D EM images. A. The crystal structure of the 
ectodomain of unliganded αVβ3 integrin. α-subunit in cyan, β-subunit in blue, sugar in yellow, and 
Ca2+ ions in red. B. The crystal structure of the headpiece of  αIIbβ3 integrin aligned with the 
headpiece of αVβ3 integrin. αIIbβ3 in pink and αVβ3 in blue. C. 2D EM images of αVβ3 integrin under 
conditions as labeled. Figure C adapated from Takagi et al. [45] 
 
headpiece [46]. In contrast, in the crystal structure of a legless αIIbβ3 integrin with ligands 
or pseudo-ligands [47], Hybrid swings out for 60~90 degree, which is called the open 
conformation (Fig. 2.10B). Furthermore, multiple global conformations of integrins were 
observed in 2D negative staining electron microscopy (EM) images (Fig. 2.10C), 
including bent, extended with a closed headpiece, and extended with an open headpiece 
conformations [45, 48, 49]. In the presence of 1mM Mn2+, the condition in which 
αVβ3 integrin was shown to have high affinity for its ligands, αVβ3  mainly adopted an 
extended conformation. But with 1mM Ca2+ and Mg2+, where αVβ3 integrin was shown to 
have low affinity for its ligands, the majority of αVβ3  had a bent conformation. A head-
to-leg disulfide bond locked αVβ3 integrin in a low-affinity state [45]. Besides, the  
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Figure 2.11 Switchblade model of integrin signaling. Three conformations: bent (A), extended with 
a closed headpiece (B), and extended with a open headpiece (C), correspond to low-affinity, 
intermediate-affinity, and high-affinity states, respectively. D. Pathways of global conformational 
changes during inside-out (lower pathway) or outside-in (upper pathway). Adapted from Xiao et al. 
[47] 
 
epitope of the activation-sensitive antibody KIM127 in EGF2/3 of β2 subunit is masked 
in the bent conformation [50]. All these data suggest that the bent conformation is the 
inactive, low-affinity state while the extended conformation is the active, high-affinity 
state. Therefore, transition between the inactive and active states requires the global 
conformational change between the bent and extended conformations.  
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 How does the transition between different conformations of integrin occur? A 
switchblade model was suggested [45, 47, 50] (Fig. 2.11). During inside-out signaling, 
binding of an intracellular protein (e.g., talin) to the integrin cytoplasmic tail causes the 
separation of α and β cytoplasmic/transmembrane domains, which induces the 
separation of the two legs of the integrin. As a result, the integrin stands up with an 
intermediate affinity and a close headpiece. Furthermore, the Hybrid domain swings out 
at the junction with the βA domain, which opens the headpiece and brings βA into a high 
affinity state for ligand binding. For outside-in signaling, ligand binding to a low affinity, 
bent integrin with a closed headpiece drives the outward Hybrid swing, leg separation, 
extension, and further separation of transmembrane and cytoplasmic segments, which 
exposes binding site for intracellular signaling molecules to assemble a cytosekeletal-
based signaling complex. 
 Alternatively, a deadbolt model [51] was proposed for inside-out signaling based 
on the fact that a bent αVβ3 integrin binds to a soluble physiologic ligand fibronection, 
containing type III domains 7-10 and the EDB domain [52] and other evidences. The CD 
loop of the βTD domain locks the βA domain in the low-affinity state. The change of the 
tilting angle of the transmembrane segaments by inside-out signals leads to the 
disengagement of the deadbolt, which switches βA into the high-affinity state. Hybrid 
swing-out and integrin extension are thought to be an outside-in signaling after ligand 
engagement. 
 The role of integrin global conformational changes is still debatable, but it most 
likely occurs at a certain stage of integrin signaling. So studying the dynamic processes 
of integrin global conformational changes is very important for understanding the 
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structure-function relations of integrins. Integrin unbending from a bent to an extended 
conformation is a 10~20 nm large-scale conformational change. How does the unbending 
occur? What are the steps during the unbending process? What are important residues for 
the unbending? To answer these questions, steered molecular dynamics (SMD) was used 
to simulate in atomic details the unbending of αVβ3 integrin in response to a tensile force. 
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CHAPTER 3 
METHODS 
MD Simulations 
 All topology and parameter files were generated using LEaP of the AMBER 8 
suite [53] with the Cornell et al. force field [54] or Duan et al. [55] force field for proteins 
and Woods et al. force field [56]  for carbohydrates. MD simulations were performed 
with the NAMD package [57]. The crystal structures for the CD16-hIgG1 Fc complex 
(pdb 1e4k), VWF A domains (pdb 1auq for A1 and 1atz for A3), αVβ3 integrin (pdb 1u8c)  
were taken from Protein Data Bank [58].  
The protein structures were placed in either spheres or rectangular periodic boxes 
of TIP3P water molecules. With water boxes, a 10-15 Å minimal distance between 
boundaries and proteins was guaranteed. Then counterions (Na+ and Cl-) were added to 
neutralize the systems, and produce 100-150 mM ionic concentration in the case of water 
boxes. The systems were initially energy-minimized with a conjugate gradient method for 
three times of 10,000 steps each: firstly all atoms of the proteins fixed, secondly only the 
backbone atoms fixed, and thirdly all atoms free. The particle mesh Ewald (PME) 
method [59] was used to treat long-range electrostatic interactions and SHAKE [60] was 
used to constrain bond lengths involving bonds to hydrogen atoms. The time-step for MD 
simulations was 2 fs with a 9 or 12 Å non-bonded cutoff. Then the systems were 
gradually heated up from 0 K to 300K or 310 K during 60-100 ps canonical ensemble 
(NVT)-MD simulations with harmonic restraints (force constants of 1 or 5 kcal mol-1 Å-2) 
to all solute atoms. Constant temperature was controlled by Langevin dynamics with a 
damping coefficient of 5 ps-1. For water boxes, subsequent isothermal isobaric ensemble 
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(NPT)-MD simulations were performed for 100-120 ps to adjust solvent density. 
Constant pressure was controlled by Langevin piston method. After that, the harmonic 
restraints on solute atoms were gradually reduced to zero during 100-120 ps NVT-MD 
simulations. The equilibrated systems were used for further production runs. 
The VMD program [61] was used for visualization and analysis, including 
drawing of protein structures, hydrogen bond measurements (defined by a <3.5 Å 
distance between donor and acceptor atoms and a >120o angle formed by donor, 
hydrogen, and acceptor atoms), and calculations of root mean square deviation (RMSD), 
root mean square fluctuation (RMSF), and solvent accessible surface area (SASA) with 
1.4 Å probe radius. Secondary structures were determined using STRIDE [62] 
incorporated in VWD. 
SMD Simulations 
 SMD simulations were performed using NAMD [57]. A group of atoms were 
chosen as SMD [63] atoms. For constant-force SMD, a given constant force was loaded 
on the SMD atoms. For constant-velocity SMD, the center of mass (COM) of the SMD 
atoms was linked to a spring with a given force constant, which moved at a given 
constant velocity. The applied potential U is as following: 
2
021 ]))(([2
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where k is the force constant, v is  the moving speed, )(tR
r
 is the current position of COM, 
0R
r
 is the initial position of COM, and nr  is the force direction. 
Targeted MD Simulations 
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 Targeted MD simulations were run with AMBER8 [53]. A simulated structure 
was forced to move toward a reference structure. An additional term is added to the 
potential function based on the mass-weighted RMSD of a set of atoms in the current 
structure compared to a reference structure as the follows: 
2)(
2
1 TGTRMSDRMSDNkE atom −⋅⋅= , 
Where E is potential energy, k is a force constant, Natom is the number of atoms selected 
to calculate current RMSD, and TGTRMSD is the target RMSD. During a simulation, 
TGTRMSD was decreased linearly from the initial value, equal to the RMSD of the 
initial simulated structure from the reference structure, to zero. 
Homology Modeling 
 A modeled sequence was aligned with a homologous sequence, whose crystal 
structure is available, using the web-based tool “needle” [64] provide on the website of 
European Bioinformatics Institute (EMBL-EBI). The alignment was then used as an input 
of MODELLER [65]. Based on the crystal structure of the template, MODELLER 
generated a 3D model structure of the model sequence. The qualities of model structures 
were evaluated by (Discrete Optimized Protein Energy) DOPE scores [66]. Finally, 
energy minimization was run to eliminate bad interactions. 
Binding Free Energy Calculation 
 The binding free energy of each complex was calculated using the Molecular 
Mechanics-Poisson Boltzmann/Generalized Born Surface Area (MM-PB/GBSA) 
approach [67, 68], which has been incorporated in AMBER 8 package. Isolated trajectory 
of each protein in the complex was obtained by extracting the corresponding portion from 
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the complex trajectory. For each MD trajectory, 150 snapshots were taken from the last 3 
ns—one snapshot every 20 ps. All water molecules and counterions were stripped. Then 
the binding free energy was calculated according to: 
i
proteinproteincomplex
total iGiGiGG )()()(
21 −−=Δ  , 
where ⋅  indicates an average over all the snapshots. )(iG x  is a sum of contributions of 
gas-phase energy, solvation free energy, and solute entropy as follows: 
   )()()()( iTSiGiHiG xxsolvation
x
gas
x −+= . 
Gas-phase energy xgasH  includes bond, angle, torsional, electrostatic, and van der Waals 
energies. Solvation free energy xsolvationG  consists of polar and non-polar contributions. 
The polar solvation free energy was calculated using the Delphi [69] to solve Poission-
Boltzmann (PB) equations or by the aoGB model [70]. Dielectric constants for the 
interior and the exterior of the solute were 1 and 80, respectively. The non-polar solvation 
free energy was estimated by solvent-accessible surface area (SASA): 
    biSASAiG xx polarnon +⋅=− )()( γ , 
where )(iSASAx  was calculated using the LCPO method [71] in AMBER 8 and γ , b 
were set to 0.00542 kcal mol-1 Å-2 and 0.92 kcal mol-1, respectively, if using the Delphi; 
or γ , b were set to 0.005 kcal mol-1 Å-2 and 0 kcal mol-1, respectively, if using the aoGB 
model. The solute entropy xS  was calculated with classical statistical thermodynamics. 
A normal mode analysis was used to obtain vibrational frequencies. 
 In addition, the effective energies, which do not include entropy contributions, 
were decomposed to the contributions of residues according to the decomposition method 
[68] implemented in the MM-PBSA program of AMBER 8 when using the aoGB model.
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CHAPTER 4 
STRUCTURAL BASIS FOR GLYCOSYLATION EFFECTS ON 
FCγRIIIB-IGG BINDING 
 
As mentioned in section 2.1, human CD16 is a highly glycosylated protein [3]. 
Experiments showed that the glycosylation of CD16 significantly decreased its binding 
affinity to IgG (Fig. 2.4) [7]. Here, computational methods were used to reveal the 
structural basis of glycosylation effects on CD16-IgG binding. 
4.1 Model of a Glycosylated CD16-IgG Fc Complex 
  
Figure 4.1 Model of a glycosylated CD16-IgG Fc complex. A. The structure of the model, which is 
rotated ~180 degree around a vertical axis if compared to Fig. 2.3. CD16bNA2 in green color, chain A 
of IgG Fc in red, and chain B in blue. Pink spheres are N-glycosylation sites. Gray sticks represent 
saccharides on IgG Fc and purple sticks indicate an N-glycan core attached to ASN159 using the web-
based “GlyProt” tool. B. Linear structures of oligosaccharide chains on IgG Fc and CD16. Galp, 
Galactopyranose; GlcpNAc, N-Acetyl-Glucosamine pyranose; Manp, Mannopyranose; Fucp, 
Fucopyranose. 
 
Only the crystal structure of an unglycosylated CD16bNA2-IgG Fc complex 
structure is available until now (Fig. 2.3) [5, 6]. To obtain a structure of a glycosylated 
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CD16-IgG Fc, I attached in silico an N-glycan core to residue ASN159 of CD16b NA2 in 
the unglycosylated CD16bNA2-IgG Fc complex (Fig. 4.1), using the web-based “GlyProt” 
tool (http://www.glycosciences.de/glyprot) developed by Bohne-Lang et al. [72] The N-
glycan oligosaccharide chain was built based on most populated N-glycan conformations 
in Protein Date Bank (PDB) and to avoid space conflicts with existing atoms. 
4.2 Free MD Simulations of the CD16-IgG Fc Complexes 
Equilibration of the Unglycosylated CD16-IgG Fc Complex 
Figure 4.2 Equilibration of the unglycosylated CD16-IgG Fc complex. A. The complex was 
soaked in a water box. Water molecules are shown as blue dots. B. RMSD of Cα atoms of Cγ3-A and 
B domain β-sheets (purple), which were used as the alignment reference, and other Cα atoms than the 
reference (red). C. RMSD of Cα atoms of Cγ3-A and B domain β-sheets (purple), Cγ2-A domain β-
sheets (red), Cγ2-B domain β-sheets (blue), and CD16 β-sheets (green). 
 
The unglycosylated CD16-IgG Fc complex was soaked in a water box (Fig. 4.2 
A), resulting in a system of ~100,000 atoms. After energy minimization, the system was 
heated up to 310 K. Finally, 5 ns free MD simulation was performed under constant 
pressure and constant temperature. The RMSD of Cα atoms, using Cγ3-A and B domain 
β-sheets as the alignment reference, gradually increases in the first 2 ns and then reached 
a plateau, indicating equilibrium (Fig. 4.2B). However, the RMSD showed quite large 
fluctuations. The RMSD of individual domains indicated that the Cγ2-A and B domains 
fluctuated a lot relative to the Cγ3-A and B domains (Fig. 4.2C). First, both Cγ2-A and B 
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domains moved away from their initial positions. Then Cγ2-A domain returned back 
while Cγ2-B domain went away further. These results demonstrated the flexibility of the 
connecting hinges between Cγ2 and Cγ3 domains. CD16 moved with its binding partner, 
the Cγ2 domains, therefore displayed large fluctuations. 
Figure 4.3 Transition of CD16 conformations. A. RMSD from the CD16-IgG Fc complex crystal 
structure: Cα atoms of D2 domain (purple), using as alignment reference, and D1 domain (blue). 
RMSD from the standalone CD16 crystal structure: Cα atoms of D1 domain (red). B. Distance 
between the center of mass (COM) of W95 and the COM of Y14 (red), and between Nε1 of W95 and 
Oη of Y14 (blue). C. Snapshots of CD16 structure at indicated time. White is crystal structure of 
CD16-IgG Fc complex, blue is crystal structure of standalone CD16, and red is simulated structure. 
Lower row is rotated along vertical axis by 90 degree relative to upper row. Residue W95 are shown 
as sticks. D. Snapshots of W95 and Y14 at indicated time. White sticks are from CD16-IgG Fc 
complex, blue sticks are from standalone CD16, and multiple color sticks are simulated (nitrogen in 
blue, oxygen atoms in red, carbon in cyan, and hydrogen in white). 
 
 25
Compared to its standalone crystal structure, CD16 in the complex crystal has a 
larger opening angle, where residue Trp95 in the D2 domain rotates ~90 degree along the 
Cα-Cβ bond toward the D2 domain (Fig. 4.3C). In the simulation, inter-domain motions 
of CD16 were observed when CD16 structures were aligned with the D2 domain (Fig. 
4.3A). Interestingly, CD16 transitioned from the conformation in its complex (open 
conformation) to the standalone conformation (close conformation). Initially, CD16 was 
in the open conformation, where the RMSD of D1 from the complex structure was larger 
than the RMSD from the standalone structure. Then the RMSD suddenly jumped up, 
corresponding to a twist motion of D1 relative to D2 (Fig. 4.3B). Finally, D1 rotated back 
but became closer to the standalone structure. Motions of residue Trp95 seems to be 
correlated to the domain motions of CD16. Trp95 first pointed inward and formed a 
hydrogen bond with Tyr14 in the D1 domain (Fig. 4.3D). Before the domain twisting, the 
hydrogen bond was broken and Trp95 suddenly flipped out (Fig. 4.3C). After CD16 got 
into the close conformation, Trp95 kept pointing outward. These results suggest that 
CD16 may have bistable conformations, and the transition between them is regulated by 
the interaction between Tyr14 and Trp95. 
 
Figure 4.4 Interactions of the unglycosylated CD16-IgG Fc complex. A. Number of hydrogen 
bonds between CD16 and IgG Fc. A hydrogen bond is defined by a <3.5 Å distance between donor 
and acceptor atoms and a >120o angle formed by donor, hydrogen, and acceptor atoms. B. Buried 
SASA due to binding. C. Contact area of two carbohydrate chains on IgG Fc, calculated as the buried 
SASA due to contacts. 
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 During the equilibration, 8-12 hydrogen bonds and 3 salt bridges existed between 
CD16 and IgG Fc, and almost equally distributed at chain A and B of IgG Fc (Fig. 4.4A 
and Table 4.1). Five residues (Leu235-Ser239) participating in hydrogen bonding locate 
at the lower hinge, bridging Fab to Fc, of chain A, which demonstrates the importance of 
this hinge to CD16 binding. The buried SASA due to binding is 800-1000 Å2. The buried 
SASA of chain B of Fc is slightly larger than that of chain A (Fig. 4.4B). Two 
carbohydrate chains on IgG Fc were interacting with each other. Their contacts were 
increased after 3 ns (Fig. 4.4C). 
Table 4.1 
Hydrogen bonds1 between CD16 and IgG Fc for the unglycosylated CD16-IgG Fc complex 
 
CD16 Chain A of IgG Fc 
Existing 
Time (ns) CD16 
Chain B of IgG 
Fc 
Existing 
Time (ns) 
Trp110 Nε1 Ala327 O 2.49 2Lys117 Nζ 2Asp265 Oδ1 1.26 
   2Lys117 Nζ 2Asp265 Oδ2 4.11 
2Lys111 Nζ 2Glu269 Oε1 0.6    
2Lys111 Nζ 2Glu269 Oε2 0.81 Asp126 Oδ1 Ser267 Oγ 5.06 
   Asp126 Oδ1 Ser267 N 4.65 
Ser157 Oγ Leu235 O 3.11    
Ser157 N Leu235 O 0.52 2Lys128 Nζ 2Glu269 Oε1 0.49 
   2Lys128 Nζ 2Glu269 Oε2 0.89 
Lys158 Nζ Pro238 O 3.82    
   His131 Nε2 Ser298 Oγ 1.49 
Lys158 Nζ Gly237 O 1.48    
   Arg152 Nη1 3NAG801 O7 0.54 
Lys158 Nζ Ser239 Oγ 1.7 Arg152 Nη2 3NAG801 O7 2.24 
   
Lys158 Nζ Gly236 O 3.21    
1. Only residue pairs, which formed hydrogen bonds for >1 ns, are listed. 
2. Salt bridges. 
3. NAG: N-Acetyl-Glucosamine pyranose. 
Equilibration of the Glycosylated CD16-IgG Fc Complex 
 Similarly, the glycosylated CD16-IgG Fc complex structure was soaked in a water 
box. After energy minimization and heat-up to 310K, 5 ns free MD was run with constant 
temperature and pressure. When aligned with the Cγ3-A and B domain β-sheets, the 
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RMSD of Cα atoms showed two plateaus in the last 3 ns (Fig. 4.5A). According to the 
RMSD of individual domains, the jump of RMSD was due to the motion of CD16 (Fig. 
4.5B). Compared to the unglycosylated CD16-IgG Fc complex, the RMSD of CD16 was  
 
Figure 4.5 Equilibration of the glycosylated CD16-IgG Fc complex. A. RMSD of Cα atoms of 
Cγ3-A and B domain β-sheets (purple), which were used as the alignment reference, and other Cα 
atoms than the reference (red). B. RMSD of Cα atoms of Cγ3-A and B domain β-sheets (purple), Cγ2-
A domain β-sheets (red), Cγ2-B domain β-sheets (blue), and CD16 β-sheets (green). C. Comparison 
of mean structures of unglycosylated and glycosylated CD16-IgG Fc complexes, aligned with Cγ3-A 
and B domain β-sheets. 
 
much larger at the high level. The RMSD of the Cγ2-A and B domains kept at 4-6 Å 
range. Interestingly, a significant conformational change was observed when the mean 
structures of the two complexes over the last 3 ns simulations were compared. In the 
glycosylated CD16-IgG Fc complex, the CD16 shifted more to the Cγ2-B domain of Fc, 
the Cγ2-B domain opened more, and the Cγ2-A domain became more closed (Fig. 4.5C). 
What caused the conformational change? In the previous simulation for the 
unglycosylated CD16-IgG Fc complex, two carbohydrate chains on chains A and B of Fc 
interacted with each other (Fig. 4.4C). However, for the glycosylated CD16-IgG Fc 
complex, the two carbohydrate chains of Fc almost have no interactions. Instead, sugar 
on chain B of Fc interacted with sugar on CD16 (Fig. 4.6A). Several hydrogen bonds 
were formed between them in the last 3 ns (Fig. 4.6B). Three residues were identified to 
be involved in hydrogen bonding between these two carbohydrate chains: fucose of sugar 
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on chain B of Fc, N-acetyl-glucosamine and mannose of sugar on CD16, although they 
did not interact with each other in the starting structure (Fig 4.6C). 
 
Figure 4.6 Interactions of carbohydrate chains on CD16 and IgG Fc. A. Contact area between 
sugar chains. Sugar AB: between sugar chains on chains A and B of IgG Fc, sugar AC: between sugar 
chains on chain A of Fc and CD16, sugar BC: between sugar chains on chain B of Fc and CD16. 
Contact area was calculated as the average of buried SASAs of two contacting partners. B. Number of 
hydrogen bonds between sugar chains on chain B of Fc and CD16. C. Snapshots of structures of sugar 
chains on chain B of Fc and CD16. Purple balls indicate Nδ2 atoms of ASN residues that carbohydrate 
chains are attached at. Three interacting residues are highlighted in multicolor (cyan: carbon, red: 
oxygen, blue: nitrogen, white: hydrogen). FUC: fucose, NAG: N-acetyl-glucosamine, MAN: mannose. 
 
 How was the binding pocket changed due to the global conformational change? 
The number of hydrogen bonds on chain A of IgG Fc was largely decreased (Fig. 4.7A 
and Table 4.2). Also, the buried SASA of chain A was reduced about 100 Å2 (Fig. 4.7B). 
Due to contacts between carbohydrate chains, the hydrogen bonds and buried SASA of 
chain B were increased. However, the total hydrogen bonds and buried SASA of CD16 
were slightly decreased. 
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Figure 4.7 Interactions of the glycosylated CD16-IgG Fc complex. A. Number of hydrogen bonds 
between CD16 and IgG Fc. A hydrogen bond is defined by a <3.5 Å distance between donor and 
acceptor atoms and a >120o angle formed by donor, hydrogen, and acceptor atoms. B. Buried SASA 
due to binding.  
 
Table 4.2 
Hydrogen bonds1 between CD16 and IgG Fc for the glycosylated CD16-IgG Fc complex 
 
CD16 Chain A of IgG Fc 
Existing 
Time (ns) CD16 
Chain B of IgG 
Fc 
Existing 
Time (ns) 
Lys19 Nζ Pro329 O 0.64 His116 Nδ1 Gly236 N 2.58 
      
Ser157 Oγ Leu 235 O 0.52 (*) 2Lys117 Nζ Asp265 Oδ2 2.96 (*) 
      
   Lys117 Nζ Gly237 O 2.62 
   
   Lys117 Nζ Ser239 Oγ 1.7 
      
   His131 Nδ1 Gly237 N 1.22 
      
   Arg152 Nη2 NAG801 O7 1.66 (*) 
   Arg152 Nη1 NAG801 O7 0.58 (*) 
      
   3FUC802 O2,3,4 3MAN4 O2,5,6 2.74 
      
   3FUC802 O2,3,4 3NAG2 O6 1.6 
1. Only residue pairs, which formed hydrogen bonds for >0.5 ns, are listed. 
2. Salt bridges. 
3. FUC: fucose, MAN: mannose, NAG: N-Acetyl-Glucosamine pyranose. 
* Existing in the unglycosylated CD16-IgG Fc complex. 
 
 In the glycosylated CD16-IgG Fc simulation, the RMSD of the D1 domain of 
CD16 from the complex crystal structure was always smaller than the RMSD from the 
standalone crystal structure (Fig. 4.8A), indicating that CD16 stayed in its complex 
conformation (Fig. 4.8C). Consistently, Trp95 still pointed inward and the hydrogen bond 
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between Tyr14 and Trp95 was formed most of time (Fig. 4.8B), although Trp95 rotated 
~90 degree along the Cβ-Cγ bond (Fig. 4.8D). 
 
Figure 4.8 CD16 conformations in the glycosylated CD16-IgG Fc complex. A. RMSD from the 
CD16-IgG Fc complex crystal structure: Cα atoms of D2 domain (purple), using as alignment 
reference, and D1 domain (blue). RMSD from the standalone CD16 crystal structure: Cα atoms of D1 
domain (red). B. Distance between the center of mass (COM) of W95 and the COM of Y14 (red), and 
between Nε1 of W95 and Oη of Y14 (blue). C. Snapshots of CD16 structure at 5 ns. White is crystal 
structure of CD16-IgG Fc complex, blue is crystal structure of standalone CD16, and red is simulated 
structure. Residue W95 are shown as sticks. D. Snapshots of W95 and Y14 at 5 ns. White sticks are 
from CD16-IgG Fc complex, blue sticks are from standalone CD16, and multiple color sticks are 
simulated (nitrogen in blue, oxygen atoms in red, carbon in cyan, and hydrogen in white). 
 
4.3 Computational Binding Free Energy of the CD16-IgG Fc Complexes 
 To evaluate quantitatively the change of CD16-IgG Fc binding strength due to the 
conformational change upon CD16 glycosylation, the MM-PB(GB)SA method was used 
to calculate binding free energy of the CD16-IgG Fc complexes. 150 snapshots for each 
complex were extracted from the last 3 ns free MD simulation for MM-PBSA calculation. 
 31
 
Figure 4.9 Computational binding free energy of the CD16-IgG Fc complexes. A. Comparison of 
computational binding free energy (ΔG) of the unglycosylated CD16-IgG Fc complex with 
experimental data from Maenaka et al. [73] PB: polar solvation energy calculated by Poisson-
Boltzmann equation, GB: polar solvation calculated using Generalized Born model, Exp: experimental 
data. B. Comparison of computational binding free energy between the unglycosylated and 
glycosylated CD16-IgG Fc complexes. C. Components of binding free energy difference (ΔΔG) 
between the two complexes. INT: internal energy including energy of bond stretching, angle bending, 
and torsion; VDW: van der Waals energy; PBELE: electrostatic energy in gas phase plus polar 
solvation energy calculated by Poisson-Boltzmann equation; PB_np: nonpolar solvation energy; TS: 
temperature times entropy. Total=INT+VDW+PBELE+PB_np-TS. D. Comparison of effective energy 
(ΔGeff) that does not include entropy contribution. Error bars indicate standard error of mean. 
 
 Two methods were used to calculate the polar solvation energy: one is Poisson-
Boltzmann equation (PB), and the other is Generalized Born model (GB). Compared to 
experimental data [73], PB gave a better result for the unglycosylated CD16-IgG Fc 
complex than GB (Fig. 4.9A). It is reasonable because GB is an approximation of PB. 
Comparing the binding free energy of the two complexes, PB predicted that the 
unglycosylated CD16-IgG Fc complex had more negative free energy while GB gave an 
opposite result (Fig. 4.9B). Standard errors are large, showing that it is very difficult for 
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Table 4.3 
Binding free energy components of the CD16-IgG Fc complexes 
a Helec, electrostatic energy; HvdW, van der Waals energy; Hint, internal energy including energy of 
bond stretching, angle bending, and torsion; Hgas= Helec + HvdW + Hint; PBnp and PBpolar, nonpolar and 
polar solvation energy calculated using the PB method; solvation energy PBsol = PBnp + PBpolar; 
effective energy PBeff = Hgas + PBsol; GBnp and GBpolar, nonpolar and polar solvation energy 
calculated using Generalized Born model; salvation energy GBsol = GBnp + GBpolar; effective energy 
GBeff = Hgas + GBsol; TStrans, translational entropy of solute; TSrot, rotational entropy of solute; TSvib, 
vibrational entropy of solutes; total entropy of solute TStrans+rot+vib = TStrans + TSrot; total free energy 
PBtotal = PBgas+sol + TStrans+rot+vib; total free energy GBtotal = GBgas+sol + TStrans+rot+vib. 
b Average over 150 snapshots, except that entropy are averaged over 30 snapshots. 
c Standard error of mean. 
 
the MM-PBSA method to predict a small free energy difference (<10 kcal/mol). On the 
other hand, PB most likely gave a better prediction as demonstrated. Therefore, the more 
negative free energy, calculated by PB, indicated that the unglycosylated complex had a 
higher binding affinity, which is consistent with experimental data (Fig. 2.4). The 
difference of ~3.55 kcal/mol between the two complexes corresponds to ~350 folds 
aComponents  
(kcal/mol) 
Unglycosylated CD16  Glycosylated CD16 
bMean cσ  bMean cσ 
Helec  -318.65  3.20   -245.09  1.67  
HvdW   -82.39  0.50   -86.16  0.48  
Hint 0.01  0.00   0.01  0.00  
Hgas   -401.04  3.18   -331.23  1.62  
PBnp -9.18 0.04 -8.89  0.04  
PBpolar 356.50  3.95   298.85  2.53  
PBsol 347.33  3.93   289.96  2.51  
PBele 37.85 1.49  53.76 2.47 
PBeff -53.71 1.41 -41.27  2.24  
GBnp -7.62  0.04   -7.35  0.04  
GBpolar    364.71  3.00   301.24  1.60  
GBsol 357.10  2.98   293.88  1.61  
GBeff -43.94  0.42   -37.35  0.52  
TStrans -16.88  0.00   -16.91 0.00  
TSrot -16.92  0.01   -16.96  0.01  
TSvib -9.74 2.13  -0.79 3.15 
TStrans+rot+vib -43.54  2.14   -34.66  3.15  
Htra/rot -1.85 0  -1.85 0 
PBtotal -12.01  2.56   -8.46  3.86  
GBtotal -2.25 2.18 -4.54  3.19  
ΔGexp -8.00 1.16    
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binding affinity difference ( ⎟⎠
⎞⎜⎝
⎛ Δ−=
RT
GK A exp ), which is one order higher than 
experimental data. 
 Among all components of the free energy difference between the two complexes 
(ΔΔG), van der Waals energy (VDW), electrostatic energy (PBELE), and entropy portion 
(TS) have the biggest contribution (Fig. 4.9C and Table 4.3). PBELE, which includes 
electrostatic energy in gas phase and polar solvation energy, has a large negative value, 
while VDW has a small positive value. This demonstrates that the change of electrostatic 
energy is more significant and the unglycosylated complex has more favorable 
electrostatic interactions, which are consistent with the observed change of hydrogen 
bonds. Entropy compensates for the change of electrostatic energy. More negative 
electrostatic energy, more loss of entropy. So the total free energy change was small, 
although its components are big. 
 The vibrational entropy of solute was calculated using normal mode analysis and 
very time consuming, so it was computed only for 30 snapshots. As a result, it has the 
biggest standard error among all the components of free energy. If the entropy portion is 
excluded, the other part of free energy (effective energy) shows the same tendency of 
binding free energy difference for PB and GB computations (Fig. 4.9D). In order to 
identify important residues for binding, a residue-based free energy decomposition was 
performed for effective energy of GB because only GB polar solvation energy can be 
decomposed to each residue. The free energy of each critical residue, which is significant 
negative, is displayed like a spike on the free energy curves (Fig. 4.10). Several important 
regions were identified. The lower hinges of both Cγ3-A and Cγ3-B of IgG Fc had a big 
contribution. Upon CD16 glycosylation, the free energy of the lower hinge of Cγ3-A 
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Figure 4.10 Residue-based decomposition of the effective energy of the CD16-IgG Fc complexes. 
Contribution of each residue of chain A of Fc (A), chain B of Fc (B), and CD16 (C). FUC: fucose, 
MAN: mannose, NAG: N-Acetyl-Glucosamine pyranose. D. Bind pockets of CD16-IgG complexes. 
Residues with biggest contribution to the effective energy are highlighted in colors: blue residues have 
more negative energy in the unglycosylated complex, red residues have more negative energy in the 
glycosylated complex, and yellow residues have almost equal energy in both complexes. 
 
became less negative while the free energy of the lower hinge of Cγ3-B turned more 
negative due to the shift of CD16 to chain B. “Proline sandwich”, including Pro329 of 
chain A of Fc and Trp87 and Trp110 of CD16, also contributed significantly to the 
binding free energy. Upon CD16 glycosylation, the proline sandwich was weakened and 
Trp87 became less negative. The C’/E loop (residue 297-299) of the Cγ3-B domain had a 
large negative free energy, which became much less when CD16 was glycosylated. 
Residue His116, Lys117, and Leu154 of CD16, which interacted with the lower hinge of 
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Cγ3-B, had much more negative free energy upon CD16 glycosylation. In contrast, the 
F/G loop (residue 155-158) of CD16, which interacted with the lower hinge of Cγ3-A, 
had much less negative free energy when CD16 was glycosylated. As observed 
interactions between the two carbohydrate chains of CD16 and Cγ3-B, sugar residues 
MAN4 of CD16 and FUC802 of chain B of Fc had a negative free energy. Other residues, 
including Asp265 and NAG801 of Cγ3-B and Tyr129 and His131 of CD16, also 
contributed largely to the binding free energy but no significant change upon CD16 
glycosylation. 
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CHAPTER 5 
UNFOLDING OF THE VWF A DOMAINS UNDER FORCE OR 
HIGH TEMPERATURE 
 
 As described in section 2.2, the unfolding of VWF A2 domain facilitates its 
cleavage by ADAMTS-13, which assures correct length distribution of VWF multimers 
in blood circulation. Here, MD was used to simulate at atomic details the dynamic 
process of the A2 domain unfolding by tensile force or under high temperature. As a 
comparison, the A1 domain unfolding was also studied. 
5.1 Unfolding of the A1 and A2 Domains by Tensile Force 
Equilibration of A1 and A2 in Water Spheres 
To prepare for the SMD simulations of the unfolding, the crystal structure of the 
A1 domain (pdb 1auq, Fig. 2.7B) [22] and the homology model of the A2 domain (Fig. 
2.7C) [25] were soaked in water spheres with diameters of 75 Å and 70 Å, respectively 
(Fig. 5.1 A and B). After energy minimization and heat-up to 300 K, the two systems 
were equilibrated under constant temperature without restraints for 1 ns. In both cases, 
the RMSDs of all Cα atoms displayed plateaus (Fig. 5.1C), indicating that the systems 
reached equilibrium quickly. The RMSD of both systems was smaller than 2 Å, showing 
that the structural changes were small during equilibration. However, the RMSD of the 
A2 domain was larger than that of the A1 domain (the N- and C-terminal loops of the A1 
domain were excluded for RMSD calculation because they are not in the core residues 
Cys1272-Cys1458 within the disulfide bond), indicating more changes in the equilibrated  
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Figure 5.1 Equilibration of the A1 and A2 domains in water spheres. The A1 (A) and A2 (B) 
domains were soaked in water spheres. Water molecules are colored blue. C. RMSD of all Cα atoms 
using the starting structures as references. Structures at different time were aligned with the β1, β2, 
β4, and β5 strands of the corresponding starting structures. D. RMSF of each Cα atom averaged over 
1 ns equilibration. Structures at different time were aligned to the starting structure via the four strands 
(β1, β2, β4, and β5). The residue numbers of A1 and A2 are shown according to their sequence 
alignment in Fig. 1 of Sutherland et al.[25] Residue 1 of A1 corresponds to residue 1261 in VWF 
sequence, while residue 15 of A2 corresponds to residue 1496 in VWF sequence. Loops that have 
large RMSF are indicated by arrows. Representations of A1 and A2 refer to Fig. 2.7. 
 
structure of the A2 domain. This is probably because the initial structure of the A2 
domain is from a homology model and may not be as close to its native structure as the 
initial structure of the A1 domain, which is a crystal structure. Furthermore, the RMSF 
for each Cα atom was calculated. The RMSF of loops β1-α1, β3-α3, and α5 of the A2 
domain was larger than that of the corresponding parts of the A1 domain (Fig. 5.1D), 
indicating the A2 domain is more flexible than the A1 domain. Outside the A1 domain  
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Figure 5.2 The A2 domain unfolding by pulling at the C-terminus. A. The start point (0 ns) of the 
SMD simulation. A force was pulling rightward on the C-terminal Cα atom (red ball) with the N-
terminal Cα atom (blue ball) fixed. B. Plot of force vs. distance between the N-terminal Cα atom and 
the C-terminal Cα atom (N-to-C length) during the SMD simulation. The force peaks are labeled with 
numbers 1-6. C. SASA of the proteolytic site vs. simulation time. D. Snapshots of the simulated A2 
domain structure. Numbers 1-6 label snapshots (taken at indicated times) that correspond to the force 
peaks 1-6 in B. Representations of A2 refer to Fig. 2.7C. 
 
core, the N- and C-terminal loops were much more flexible, with large RMSF, as 
expected. 
Unfolding of the VWF A2 Domain by a Tensile Force 
To simulate unfolding by force with SMD, the C-terminal Cα atom of the A2 
domain was pulled at a constant speed of 5 nm ns-1 through a spring (spring constant of 1 
kcal mol-1 Å-2) attached to the C-terminal Cα atom while the N-terminal Cα atom was 
fixed (Fig. 5.2A). The force-extension curve displayed six peaks (Fig. 5.2B). The first  
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Figure 5.3 The A2 domain unfolding by pulling at the N-terminus. A. The start point (0 ns) of the 
SMD simulation. A force was pulling leftward on the N-terminal Cα atom (blue ball) with the C-
terminal Cα atom (red ball) fixed. B. Plot of force vs. distance during the SMD simulation. The force 
peaks ars labeled with numbers 1-6. C. SASA of the proteolytic site vs. simulation time. D. Snapshots 
of the simulated A2 domain structure. Numbers 1-6 label snapshots (taken at indicated times) that 
correspond to the force peaks 1-6 in B. Representations of A2 refer to Fig. 2.7C. 
 
three peaks corresponded to the sequential pullouts of the β6, β5, and β4 strands of the 
central β-sheet from the C-terminus (Fig. 5.2D, 1-3). Instead, the fourth peak showed the 
pullout of the β1 strand from the N-terminus (Fig. 5.2D, 4). The second and third peaks 
had higher peak forces than the first and fourth peaks, indicating stronger intradomain 
interactions of the β5 and β4 strands. Unfolding of the remaining structure, which 
included the α1 and α3 helices and the β2 and β3 strands (Fig. 5.2D, 5), resulted in two 
peaks that were much smaller than the first four peaks. The fifth peak appeared when the 
α3 helix was pulled out and unfolded (Fig. 5.2D, 5). Finally, the breakage of the β2-β3 
hairpin gave the sixth peak (Fig. 5.2D, 6).  
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 To examine how the proteolytic site would become exposed during the unfolding 
of the A2 domain, the SASA for the backbone and the sidechain of Tyr1605 and 
Met1606, two residues adjacent to the proteolytic site on the β4 strand, was calculated 
(Fig. 5.2C). The SASA curve of the sidechain showed three steps while that of the 
backbone had two steps. Initially, the two residues were completely buried, as indicated 
by the zero SASA of the sidechain and the backbone. After the pulling was started, the 
α7 helix was pulled out first to partially expose the proteolytic site, resulting in a sudden 
jump in the SASA of the sidechain to 50 Å2. But the SASA of the backbone was still zero 
because the backbone of the β4 strand was buried by its neighboring β1 and β5 strands. 
Then, one side of the backbone was exposed when the β5 strand was pulled out (Fig. 
5.2D, 2), producing a sudden jump in the SASA of both the sidechain and the backbone. 
Finally, the β4 strand on which the proteolytic site resides was pulled out (Fig. 5.2D, 3), 
giving rise to the last jump in the SASA values. 
 Considering that the pulling speed in SMD is several orders of magnitude higher 
than that in experiments such as those done with atomic force microscopy (AFM), there 
is always a question whether the force propagates well through an object that is pulled. 
To address this for the A2 domain, a second SMD simulation was run where force was 
loaded along the opposite direction on the N-terminal Cα atom with the C-terminal Cα 
atom fixed (Fig. 5.3A) and the same pulling speed and spring constant. The results 
showed that the A2 domain unfolding still started from the C-terminus (Fig. 5.3D). Just 
as the first SMD, the β6, β5, and β4 strands of the A2 domain were pulled sequentially 
out of the central β-sheet (Fig. 5.3D, 1-3), which resulted in the first three peaks in the 
force-extension curve (Fig. 5.3B). Then a much smaller peak was observed, indicating 
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the pullout and unfolding of the α4 helix (Fig. 5.3D, 4). This peak was not observed in 
the first SMD simulation. After the fourth peak, the β1 strand was pulled out from the N-
terminus (Fig. 5.3D, 5), resulting in the fifth peak, which corresponded to the fourth peak 
in the first SMD simulation. The unfolding of the remaining structure (α1 and α3 helices 
and β2 and β3 strands) generated some small peaks (Fig. 5.3D, 6), but much less 
pronounced than those in the first SMD simulation. Since most features of the two 
simulated unfolding processes were similar with the four major peaks (corresponding to 
the pullouts of β6, β5, β4, and β1) appearing in both force-extension curves in the same 
sequence, it was concluded that the A2 domain unfolded along the same pathway in both 
cases. This suggests that the force actually propagated well through the whole A2 domain 
regardless of whether it was pulled at the N- or the C-terminus. 
 Just as in the first SMD simulation, the SASA curves of the sidechain and the 
backbone of the proteolytic site include three and two steps, respectively (Fig. 5.3C). The 
exposure of the proteolytic site became more gradually: the pullout of the α7 helix first 
exposed part of the sidechain of the proteolytic site but not the backbone, the pullout of 
the β5 strand then exposed one side of the backbone, the pullout of the β4 strand finally 
fully exposed the proteolytic site. 
Unfolding of the VWF A1 Domain by a Tensile Force 
As mentioned, the A1 domain has a disulfide bond that links its C- and N-termini. 
It is therefore expected that the A1 domain is harder to unfold than the A2 domain, 
especially under tensile force. When a spring (spring constant = 1 kcal mol-1 Å-2) attached 
to the C-terminal Cα atom of the A1 domain was pulled at a constant speed of 5 nm ns-1 
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Figure 5.4 Unfolding of the A1 domain with an intact disulfide bond by pulling at the C-
terminus. A. The start point (0 ns) of the SMD simulation. A force was pulling rightward on the C-
terminal Cα atom (red ball) with the N-terminal Cα atom (blue ball) fixed. B. The structure of the A1 
domain at the end of the SMD simulation (2 ns). C. Plot of force vs. distance during the SMD 
simulation. Representations of A1 refer to Fig. 2.7B. 
 
(the N-terminal Cα atom fixed, Fig. 5.4A), the force increased gradually to a value higher 
than 2,000 pN (Fig. 5.4C). The force could have increased to infinite because the 
disulfide bond is not allowed to break in a classic MD simulation. At 2 ns, the end of the 
SMD simulation, the N- and C-terminal loops of the A1 domain were stretched tautly 
(Fig. 5.4B), but the core of the A1 domain was not affected at all due to the presence of 
the disulfide bond. 
 In reality, the disulfide bond can be broken by reducing agents such as DTT [74, 
75], enzymes that catalyze disulfide bond reduction such as Thioredoxin [76], or even a 
very large force. Since the disulfide bond in the A1 domain is exposed, it is susceptible to 
reduction. In order to simulate the unfolding of the A1 domain after reduction of its 
disulfide bond, we manually broke the disulfide bond at the beginning of the SMD 
simulation while keeping other setup of the simulation the same (Fig. 5.5A). During the 
pulling, the α7 helix was pulled out at first (Fig. 5.5C, 1). The unfolding of the α7 helix 
resulted in small force peaks in the force-extension curve (Fig. 5.5B). Then the β6 strand 
was pulled out, generating a small force peak (Fig. 5.5C, 2). After that, the β5 strand was 
pulled out (Fig. 5.5C, 3), causing the third force peak, followed by the pullout of the β4  
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Figure 5.5 Unfolding of the A1 domain with a broken disulfide bond by pulling at the C-
terminus. A. The start point (0 ns) of the SMD simulation. The disulfide bond was broken in silico. A 
force was pulling rightward on the C-terminal Cα atom (red ball) with the N-terminal Cα atom (blue 
ball) fixed. B. Plot of force vs. distance during the SMD simulation. The force peaks are labeled with 
numbers 1-6. C. Snapshots of the simulated A1 domain. Numbers 1-6 label snapshots (taken at 
indicated times) that correspond to the force peaks 1-6 in B. Representations of A1 refer to Fig. 2.7B. 
 
strand, producing the highest force peak (Fig. 5.5C, 4). The β1 was then pulled out from 
the N-terminus, yielding the fifth force peak with only α1, α2, β1, and β2 in the 
remaining structure (Fig. 5.5C, 5). Finally, the remaining structure was unfolded (Fig. 
5.5C, 6), giving rise to the sixth force peak. 
Hydrogen Bond Network of β Sheet Determines Unfolding Resistance to Tensile 
Force 
As shown above, the A2 domain unfolding always started from the C-terminus 
with the same sequence of β strand pullouts regardless of whether the A2 domain was 
pulled at the C- or N-terminus. When it was pulled at the C-terminus, the A1 domain  
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Figure 5.6 Topology and hydrogen bond networks of the central β-sheet of the A domains. A. 
The topology of the A domains. Cyan arrows indicate β strands and purple cylinders represent α 
helices (α5 is a loop in A2). Generated by TopDraw [77]. A1 (B) and A2 (C) hydrogen bond (blue 
dash line) networks in the central β-sheet. 
 
unfolding with a broken disulfide bond also started from the C-terminus. Since the 
sequences of the A1 and A2 domains are quite different (only ~20% identity), the 
similarity of their unfolding pathways may be attributed to their specific topology (Fig. 
5.6A). Since the C-terminus of the A domains started at the β6 strand on one edge of the 
central β-sheet, which forms only 3 hydrogen bonds with the β5 strand (Fig. 5.6 B and 
C), the β6 strand can be easily pulled out. In contrast, the N-terminus of the A domains 
started at the β1 strand right in the middle of the central β-sheet, which has more than 10 
hydrogen bonds with the neighboring β4 and β2 strands (Fig. 5.6 B and C), which is 
harder to break. Only after one of the neighboring β strands is pulled out to expose the β1 
strand can it be pulled out. This is exactly what was observed in the forced unfolding 
simulations. 
The force peaks in the force-extension curves are attributed as the forces required 
to pull out the β strands (i.e., pullout forces) because the force peaks were observed to 
follow the β strand pullouts during the unfolding processes. To identify the atomic-level 
interactions that contribute to the pullout forces, the changes of the hydrogen bonds of the  
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Figure 5.7 Coincidence of pullout forces and changes in numbers of hydrogen bonds. Figs. 5.2B, 
5.3B, and 5.5B are replotted in A, B. and C. Numbers of hydrogen bonds of the β-sheet and each 
strand (indicated) are plotted vs. time for A2 pulled at C- (D.) or N- (E) terminus, or A1 without the 
disulfide bond pulled at C-terminus (F). A hydrogen bond is defined by a <3.5 Å distance between 
donor and acceptor atoms and a >120o angle formed by donor, hydrogen, and acceptor atoms. 
 
central β-sheet were monitored. It is evident from Fig. 5.7 that the force peaks coincided 
with the step decrease of the hydrogen bond number, except for the 4th peak in Fig. 5.7C, 
which corresponded to the unfolding of the α4 helix. Therefore, most resistance to 
unfolding by force came from the hydrogen bond network of the central β-sheet. 
 Different β strands required different magnitudes of pullout forces. The pullout 
forces for the β5 and β4 strands (peak 2 and 3 for A2 or peak 3 and 4 for A1) were larger 
than the others because more than five hydrogen bonds have to be broken in order to pull 
out the β5 and β4 strands (Fig. 5.6). To pull out the β1 strand also needs to break more 
than five hydrogen bonds; but it required a much lower pullout force (peak 4 for pulling 
A2 at the C-terminus, peak 5 for pulling A2 at the N-terminus, or peak 5 for pulling A1 at 
the C-terminus). The reason for this difference lies in the different unfolding pathways. 
The pullouts of the β5 and β4 strands followed a sliding pathway with two β strands  
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Figure 5.8 Two pathways of β strand pullouts. The β5 (A) and β4 (B) were pulled out along a 
sliding pathway. C. The β1 pullout followed an unzipping pathway. β strands are shown as ribbons 
with arrows, backbones are shown as sticks, hydrogen bonds are represented by blue dash lines, and 
the N-terminal is marked by a blue sphere. 
 
sliding relative to each other in the direction along the long axis (Fig. 5.8 A and B). The 
old hydrogen bonds broke, and then the β strand started to slide. During sliding, new 
hydrogen bonds formed and then broke. For sliding to occur, all hydrogen bonds had to 
be broken at the same time, resulting in a large force. In contrast, the pullout of the β1 
strand was along an unzipping pathway (Fig. 5.8C). The hydrogen bonds started to break 
from one end, and then propagated to the other end. Only one hydrogen bond broke each 
time, therefore requiring a small force. 
Helices Unfolding is Different between A1 and A2 
As mentioned, the A1 and A2 domains unfolded quite similarly in terms of the β 
strand pullouts. To further quantify the changes of secondary structures during unfolding, 
mean residue molar ellipticity in circular dichroism of the A domain structures was 
calculated as a linear combination of basic spectra of secondary structures (helix, β-sheet, 
turn, and coil) [78]. First, calculated spectra of the A1 and A2 domain were compared 
with experimental measurements [29]. The calculated spectra were comparable to the  
 47
 
Figure 5.9 Mean residue molar ellipticity of the A domain structures. A. Calculated mean residue 
molar ellipticity (Θ) spectra of A1 and A2 (A1_cal and A2_cal) are compared with experimental 
values (A1_exp and A2_exp) measured in circular dichroism (from Ref. 18). B. The simulation time 
dependent ellipticities at 222 nm (Θ222) of A2 pulled at C- (A1_Cterm) or N- (A1_Nterm) terminus, or 
A1 with a broken disulfide bond (A1). C. Number of residues in the helices of A2 pulled at C- 
(A1_Cterm) or N- (A1_Nterm) terminus, or A1 with a broken disulfide bond (A1) are plotted vs. 
simulation time. 
 
experimental values of the A1 domain in wavelengths ranging from 200-260 nm, but 
differed in the 190-200 nm wavelength range (Fig. 5.9A). The experimental data showed 
significant differences between the A1 and A2 domains. But the computational results 
did not show much difference. This may indicate that the homology model of the A2 
domain is different from its native structure. Furthermore, the ellipticity at 222 nm 
(where the helix spectrum are dominant) during unfolding was calculated. The curves of 
the A2 domain pulled at the C- or N-terminus almost overlapped (Fig. 5.9B), indicating 
the unfolding of secondary structures was quite similar. However, the curves of the A1 
domain were different and had clear stepwise increase. This is because the helices of the 
A1 domain were unfolded in steps while the unfolding of the helices of the A2 domain 
was more continuous (Fig. 5.9C).  
 
 
 
 
 48
5.2 Thermal Unfolding of the A1 and A2 Domains under High Temperature 
Equilibration of A1 and A2 in Water Boxes 
 
Figure 5.10 Equilibration of the A1 and A2 domains in water boxes. The A1 (A) and A2 (B) 
domains were soaked in water boxes. Water molecules are colored blue. C. RMSD of all Cα atoms 
using the starting structures as references. Structures at different time were aligned with the β1, β2, 
β4, and β5 strands of the corresponding starting structures. D. RMSF of each Cα atom averaged over 
10 ns equilibration. Structures at different time were aligned to the starting structure via the four 
strands (β1, β2, β4, and β5). The residue numbers of A1 and A2 are shown according to their 
sequence alignment in Fig. 1 of Sutherland et al.[25] Residue 1 of A1 corresponds to residue 1261 in 
VWF sequence, while residue 15 of A2 corresponds to residue 1496 in VWF sequence. Loops that 
have large RMSF are indicated by arrows. Representations of A1 and A2 refer to Fig. 2.7. 
 
How would the SMD-simulated unfolding compare with unfolding by denaturants 
(e.g., urea)? The pathways of unfolding by denaturants and by tensile force were 
expected to be different. For example, the A1 domain can be unfolded upon addition of 
urea even with its intact disulfide bond [29]. To mimic the unfolding of the A domains 
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with denaturants, MD simulations under high temperature were performed because the 
thermal forces caused by Brownian motions act on all the part of the A domains as 
denaturants do. Indeed, MD under high temperature has been widely used to study 
protein folding and unfolding [79-83]. 
The A1 and A2 domains were soaked in water boxes (Fig. 5.10 A and B) instead 
of water spheres because water boxes were more convenient to adjust the pressure to 
avoid artifacts caused by high pressure when temperature was increased. After energy 
minimization and heat-up to 300 K, the two systems were equilibrated under constant 
temperature and constant pressure without restraint for 10 ns. The RMSD of all Cα atoms 
rapidly arrived at plateaus (Fig. 5.10C), indicating that equilibrium was reached. Similar 
to water spheres, the RMSD of the A2 domain was higher than that of the A1 domain 
probably because the structure of the A1 domain is closer to the native structure. The A2 
domain displayed higher RMSF in loops β1-α1, α1-β2, and α5 than the corresponding 
parts of the A1 domain (Fig. 5.10D), suggesting that the A2 domain was more flexible 
than the A1 domain. The N- and C-terminal loops of the A1 domain out of the disulfide 
bond Cys1272-Cys1458 showed the largest RMSF because they were most flexible. 
Thermal Unfolding of the VWF A2 Domain at 500 K 
After equilibration at 300 K, the temperature of the A2 system was increased to 
500 K in 100 ps with constant volume, so the pressure was elevated to 4 kilobar. Then the 
pressure was adjusted to 1 atm (1.01325 bar) by changing the system volume (Fig. 
5.11A). As a result, the density of the system was lowered to ~0.7 g ml-1 (Fig. 5.11B), 
similar to published simulations with SPC water model [84]. During the heat-up and the 
pressure adjustment, the A2 domains were restrained. In preliminary simulations, higher  
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Figure 5.11 Thermal unfolding of the A2 domain at 500 K. A. The temperature of the system (blue 
lines) was heated up from 300 K to 500 K in 100 ps. Then the pressure (red lines) was adjusted to 1 
atm (1.01325 bar). B. During the pressure adjustment, the density of the system decreased from ~1 g 
ml-1 to ~0.7 g ml-1. C. RMSD of Cα atoms of α5, α6, β6, and α7 using the starting structure as 
reference is plotted versus simulation time. Structures at different time were aligned to the starting 
structure via the four strands (β1, β2, β4, and β5). Inset include RMSDs of all Cα atoms (all), Cα 
atoms of β1, β2, β4, and β5 used for alignment (ref), or Cα atoms of other than the four strands 
(noref). D. SASA of the proteolytic site is plotted versus simulation time. The SASA of the backbone 
of Tyr1605 and Met1606 at the proteolytic site is shown as blue lines while the SASA of the sidechain 
is indicated as red lines. E. Snapshots of the structure of the A2 domain during the thermal unfolding 
 51
simulation. The α7 helix is colored in orange, the β6 strand in cyan, the α6 helix in purple, and the 
α5-loop in yellow. The time of each snapshot is indicated in the parenthesis. 0 ns is the moment when 
the restraints on the A2 domain were turned off. Representations of A2 refer to Fig. 2.7C. 
 
temperature was tried in order to accelerate the unfolding process. But water was rapidly 
evaporated to gas phase with higher temperature such as 600 K. Finally, all the restraints 
on the A2 domain were released and its unfolding was observed under constant 
temperature (500K) and constant pressure (1 atm). 
 The RMSD of all Cα atoms of the A2 domain displayed stepwise increase during 
its unfolding process (inset of Fig. 5.11C). The most significant changes occurred at the 
C-terminal portion of the A2 domain. The β6 strand, the α5, α6, and α7 helices displayed 
the largest RMSDs (Fig. 5.11C). First, the α6 and α7 helices moved away from the 
central β-sheet, which pushed the α5-loop aside and opened a space for exposure of the 
proteolytic site (Fig. 5.11E, 6 ns). Second, the α6 helix was unfolded into a loop (α6-
loop) while part of the α5-loop became a helix (Fig. 8E, 15 ns). Third, the α6-loop 
moved upward, the β6 strand was disconnected from the central β-sheet and converted 
into a loop (β6-loop), and the α7 helix was split into two helices (Fig. 5.11E, 26 ns). 
Fourth, the α6-loop moved rightward while the β6-loop moved upward (Fig. 5.11E, 35 
ns). At the end of the simulation, the α6-loop and β6-loop moved further away from the 
protein core while the α7 helix was mostly unfolded (Fig. 5.11E, 46 ns), so the RMSD 
kept increasing. 
 During the unfolding of the A2 domain, the SASA of the sidechain of the 
proteolytic site fluctuated around 20 Å2 (Fig. 5.11D), showing partial exposure of the 
sidechain. In contrast, the SASA of the backbone was almost zero because the 
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interactions between the β4 strand, where the proteolytic site is, and its neighbour strands 
(β1 and β5) were still intact. 
Thermal Unfolding of the VWF A1 Domain at 500 K   
Figure 5.12 Thermal unfolding of the A1 domain at 500 K. A. The temperature of the system (blue 
lines) was heated up from 300 K to 500 K in 100 ps. Then the pressure (red lines) was adjusted to 1 
atm (1.01325 bar). B. During the pressure adjustment, the density of the system decreased from ~1 g 
ml-1 to ~0.7 g ml-1. C. RMSD of Cα atoms of β3, α3, α4, β6, and α7 using the starting structure as 
reference is plotted versus simulation time. Structures at different time were aligned to the starting 
structure via the four strands (β1, β2, β4, and β5). Inset include RMSDs of all Cα atoms (all), Cα 
atoms of β1, β2, β4, and β5 used for alignment (ref), or Cα atoms of other than the four strands 
(noref). D. Snapshots of the structure of the A1 domain during the thermal unfolding simulation. The 
α3 helix is colored in orange, the β3 strand in green, the α4 helix in purple, the α7 helix in black, and 
the β6 strand in yellow. The time of each snapshot is indicated in the parenthesis. 0 ns is the moment 
when the restraints on the A1 domain were turned off. Representations of A1 refer to Fig. 2.7B. 
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Similar to the A2 domain, the temperature of the A1 system was increased to 500 
K in 100 ps with constant volume while the pressure went up to 4 kilobar (Fig. 5.12A). 
By changing the system volume, the pressure was adjusted back to 1 atm while the 
density of the system decreased to ~0.7 g ml-1 (Fig. 5.12B). The RMSD of all Cα atoms 
of the A1 domain firstly jumped to 4 Å and reached a plateau until 10 ns (inset of Fig. 
5.12C). In contrast to the A2 domain, the major changes occurred at the N-terminal 
portion of the A1 domain. The β3 strand, the α3, and α4 helices showed the largest 
RMSDs (Fig. 5.12C). During the first jump of the RMSD of all Cα atoms, the α3 helix 
and the β3 strand started to unfold while the α4 helix was elongated (Fig. 5.12D, 8ns). 
From 10 to 20 ns, the RMSD of all Cα atoms increased continuously. During this period, 
the β3 strand turned into a helix (β3 helix) (Fig. 5.12D, 13ns), and then the β3 helix 
moved up- and leftward (Fig. 5.12D, 17ns). Finally, the RMSD of all Cα atoms reached a 
plateau with 10 Å. Both the α3 and β3 helices flipped upward while the α4 helix was 
unfolded and also moved upward (Fig. 5.12D, 26 ns). Meanwhile, on the other side of the 
A1 domain, the β6 strand was converted to a helix (β6 helix) and the α7 helix was 
divided into two helices (Fig. 5.12D, 26 ns (α7 side)).   
Comparing the thermal unfolding of the A2 and the A1 domains, it was found that 
the most significant variations occurred at different locations: the C-terminal portion in 
the A2 domain, but the N-terminal portion in the A1 domain. This reflected their 
sequence difference, which affects the structure packing and thus the stability. 
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CHAPTER 6  
UNBENDING OF αVβ3 INTEGRIN UNDER FORCE 
 
As mentioned in section 2.3, experimental data suggest that integrin undergoes 
large-scale conformational changes during its bi-directional, inside-out or outside-in, 
signaling processes. In this chapter, SMD simulations were applied to study the 
unbending of αVβ3 integrin from the bent to the extended conformation induced by a 
tensile force. 
6.1 Homology Models of the Unresolved EGF1/2 Domains of αVβ3 Integrin 
In the crystal structure of the full ectodomain of αVβ3 integrin (pdb 1u8c), the 
EGF1/2 domains at the knee of β subunit were unresolved. The unresolved portion 
includes ~90 residues, which is ~6% of the whole ectodomain. In order to get a complete 
ectodomain structure, MODELLER[65] was used to build the unresolved EGF1/2 
domains. A crystal structure of β2 subunit (pdb 2p28) [85], which includes Hybrid, PSI, 
and EGF1/2/3 domains, was used as the template. β2 and β3 subunits have ~40% 
sequence identity and ~55% similarity in the modeling region of PSI, and EGF1/2 
domains (Fig. 6.1A), so β2 crystal structure is a really good template for homology 
modeling of β3. First, the Hybrid and EGF3 domains of the αVβ3 crystal structure (pdb 
1u8c) were aligned with the Hybrid and EGF3 domains of the β2 crystal structure, 
respectively (Fig. 6.1B). Fixing the Hybrid and EGF3 domains, the PSI and EGF1/2 
domains were then built. The resulted model had a similar quality as the template 
according to DOPE scores [66] (Fig. 6.1C). 
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Figure 6.1 Homology models of the unresolved EGF1/2 domains. A. Sequence alignment of PSI, 
EGF1, and EGF2 domains between β2 and β3. Generated by “needle” [64] of EMBL-EBI. B. 
Structural alignment between template (pdb 2p28) and model. Left is before model building and right 
is after. C. DOPE scores of template and model structures. 
 
Because the template of the β2 crystal structure is in an extended conformation, 
the model of β3 subunit ended up in an extended conformation. To fit the extended β3 
model in the bent αVβ3 crystal structure, a targeted MD simulation with implicit water 
was run to bend the extended model. First, the EGF3 domain was restrained and Cα 
atoms of the β-sheet of the Hybrid domain were used as the target. Gradually, the β3 
model bent over toward its target (Fig. 6.2A). Second, all the heavy atoms in the Hybrid, 
PSI, and EGF3 domains were used as the target. The model became closer to the target.  
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Figure 6.2 Targeted MD to fit the extended model in the bent crystal structure. A. Process of 
bending of β3 model (red). Crystal structure of αVβ3 (pdb 1u8c) was used as target (white). B. Final 
model in the bent crystal structure. C. RMSD of all heavy atoms of PSI and EGF1/2 domains from the 
targeted crystal structure. 
 
Finally, force constant was increased to 1 kcal mol-1, so the RMSD of the model from the 
target further decreased to ~3 Å (Fig. 6.2C). The final model did not conflict with αV 
subunit in the crystal structure. It also kept similar DOPE score as initial model, 
indicating that targeted MD did not distort the model badly. 
6.2 Equilibration of Bent αVβ3 Integrin in a Water Box 
 The complete structure of αVβ3 ectodomain, except for the unresolved Calf2 EE’ 
loop, was soaked in a water box (Fig. 6.3A). The protein included 1,617 residues and the 
systems had ~250,000 atoms in total. After system energy minimization and heat-up to 
300 K, a free MD simulation was run for ~40 ns. The RMSD from the initial structure of 
the protein reached a plateau after 5 ns. However, a small jump was seen at 15 ns. The  
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Figure 6.3 Equilibration of bent αVβ3 in a water box. A. The complete ectodomain of αVβ3 was 
soaked in a water box. α-subunit is in cyan, β-subunit is in pink, and water in blue. Red balls represent 
calcium ions and yellow sticks indicate sugar residues attached on the protein core. B. RMSD from 
the initial structure of Cα atoms, backbone, or heavy atoms during the equilibration process. 
 
following analysis will show that it corresponds to the relaxation of the modeled part at 
the knee. 
During the equilibration, extensive interactions existed between α- and β-subunits 
as shown in Fig. 6.4. The total buried SASA of each subunit was ~4,000 Å2, half of 
which was between the βA and β-propeller domains. Besides, a protruding β hairpin of 
the β-propeller domain had a little contact (<100 Å2 buried SASA) with the Hybrid 
domain of β-subunit. Similarly, among ~30 hydrogen bonds in total, half was between 
the βA and β-propeller domains. The contacts between the β hairpin of the β-propeller 
domain and the Hybrid domain were two salt bridges (Asp306/Lys384 and 
Lys308/Glu358) (Table 6.1). Around the knee region, Thigh and Calf1 of α-subunit and 
EGF2 and EGF3 of β-subunit contacted with each other. Initially, their contacts were 
decreased due to the relaxation of the built homology models. Then the buried SASAs 
became stable at 200-500 Å2. About five hydrogen bonds formed for each domain. In the 
lower leg region, Calf2 of α-subunit had ~800 Å2 contact area and ~7 hydrogen bonds  
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Figure 6.4 Interactions between α- and β-subunits of αVβ3. Buried SASA in total and in the 
headpiece region (A), in the knee region (B), or in the lower legs (C). Hybrogen bonds formed in total 
and in the headpiece region (D), in the knee region (E), or in the lower legs (F). 
 
Table 6.1 
Major hydrogen bonds between α- and β-subunits of αVβ3 
α-subunit β-subunit Existing Time (ns) α-subunit β-subunit 
Existing 
Time (ns) 
*Asp306 Oδ1 
(β-propeller) 
*Lys384 
Nζ (Hybrid) 3.5 
*Arg303 Nη1 (β-
propeller) 
*Asp565  
Oδ1 (EGF4) 
7.8 
*Asp306 Oδ2 
(β-propeller) 
*Lys384 Nζ 
(Hybrid) 4.5 
Arg783 
Nη1 (Calf2) 
Ser593 O 
(EGF4) 13.8 
*Lys308 Nζ (β-
propeller) 
*Glu358 
Oε1 (Hybrid) 2.5 
Arg783 
Nη2 (Calf2) 
Ser593 O 
(EGF4) 6.7 
*Lys308 Nζ (β-
propeller) 
*Glu358 
Oε2 (Hybrid) 2.3 
Arg783 
Nη1 (Calf2) 
Ser589 O 
(EGF4) 9.2 
Lys503 
Nζ (Thigh) 
Ser510 O 
(EGF2) 21.2 
Arg783 
Nη2 (Calf2) 
Ser589 O 
(EGF4) 11 
*Glu661 
Oε1 (Calf1) 
*Arg489 
Nη2 (EGF2) 
17.6 Arg783 Nη1 (Calf2)
Gln590 O 
(EGF4) 8.5 
*Glu661 
Oε2 (Calf1) 
*Arg489 
Nη2 (EGF2) 
12.9 Arg745 Nε (Calf2) 
Thr603 
Oγ1 ( β-ankle) 6.4 
*Glu661 
Oε2 (Calf1) 
*Arg489 
Nη1 (EGF2) 
9.6 Arg745 Nη2 (Calf2) 
Thr603 
O ( β-ankle) 4.5 
*Glu661 
Oε2 (Calf1) 
*Arg489 
Nη1 (EGF2) 
7.4 Arg745 Nη2 (Calf2) 
Thr603 
O γ1 ( β-
ankle) 
3.7 
Arg665 
Nη1 (Calf1) 
Glu522 O 
(EGF2) 9 
*Glu769 
Oε1 (Calf2) 
*Lys650 
Nε ( βTD) 13.3 
*Asp652 
Oδ1 (Calf1) 
*Lys532 
Nζ (EGF3) 
15.8 
*Glu769 
Oε2 (Calf2) 
*Lys650 
Nε ( βTD) 13.8 
*Asp652 
Oδ2 (Calf1) 
*Lys532 
Nζ (EGF3) 
18.9 
*Glu770 
Oε2 (Calf2) 
*Lys650 
Nε ( βTD) 12.2 
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Arg698 
Nη1 (Calf1) 
Tyr557 
Oη (EGF3) 
9.2 Ser749 O (Calf2) 
Thr609 
Oγ1 ( βTD) 11.1 
Ser305 Oγ (β-
propeller) 
Trp553 
Nε1 (EGF3) 
10.8 Gly925 O (Calf2) 
Lys658 
Nε ( βTD) 10.3 
   Ser749 O (Calf2) 
Asp606 
N ( βTD) 9.9 
Domains are indicated in parenthesis. Hydrogen bonds between β-propeller and βA are not included. 
* Salt bridges. 
 
with EGF4, β-ankle (a small loop between EGF4 and βTD constrained by a disulfide 
bond), and βTD. 
The simulated αVβ3 was kept in a bent conformation during the equilibration 
because of strong interactions between the headpiece and tailpiece, especially for β-
subunit (Fig. 6.5). The total contact area between the headpiece and tailpiece of β-subunit 
was ~1400 Å2 while it was only ~500 Å2 for α-subunit. Similarly, β-subunit had ~20 
hydrogen bonds while α-subunit only 5. A sudden drop of buried SASA and hydrogen 
bonds was observed for β-subunit at 15 ns because of the adjustment of the structure at 
the knee region, which also caused the jump of RMSD as mentioned. The interactions  
 
Figure 6.5 Interactions between the headpiece and tailpiece of αVβ3. Buried SASA in total (A), in 
the knee region (B), or in other regions (C). Hybrogen bonds formed in total (D), in the knee region 
(E), or in other regions (F). 
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Table 6.2 
Major hydrogen bonds between the headpiece and tailpiece of αVβ3 
Headpiece Tailpiece Existing Time (ns) Headpiece Tailpiece 
Existing 
Time (ns) 
His591 Nε2 
(Thigh) 
Glu640 Oε2 
(Calf1) 36.1 
*Asp346 Oδ1 
(βA) 
*Lys676 
Nζ ( βTD) 15.3 
Ile592 O 
(Thigh) 
Tyr639 Oη 
(Calf1) 29.9 
*Asp346 Oδ2 
(βA) 
*Lys676 
Nζ ( βTD) 13 
Gln589 Oε2 
(Thigh) 
Asn685 N δ2 
(Calf1) 1.91 
Cys374 O 
(Hybrid) 
Arg633 Nε 
(βTD) 35.4 
*Arg8 Nη2 
(PSI) 
*Glu490 Oε1 
(EGF2) 31.2 
Cys374 O 
(Hybrid) 
Arg633 Nη2 
(βTD) 15.5 
*Arg8 Nε 
(PSI) 
*Glu490 Oε1 
(EGF2) 22.5 
Gly388 O 
(Hybrid) 
Arg633 Nη1 
(βTD) 33.4 
*Arg8 Nε 
(PSI) 
*Glu490 Oε2 
(EGF2) 15.4 
*Asp393 Oδ2 
(Hybrid) 
*Arg633 Nη1 
(βTD) 30.3 
*Arg8 Nη2 
(PSI) 
*Glu490 Oε2 
(EGF2) 12.9 
*Asp393 Oδ2 
(Hybrid) 
*Arg633 Nη2 
(βTD) 26.1 
Gly465 N 
(EGF1) 
Asp484 O 
(EGF2) 31.8 
*Asp393 Oδ1 
(Hybrid) 
*Arg633 Nη2 
(βTD) 24.6 
Asn452 Oδ1 
(EGF1) 
Gln482 Nε2 
(EGF2) 30.2 
*Asp393 Oδ1 
(Hybrid) 
*Arg633 Nη1 
(βTD) 12.6 
Asn452 Nδ2 
(EGF1) 
Gln482 Oε1 
(EGF2) 26 
Asp393 Oδ1 
(Hybrid) 
Asn632 Nδ2 
(βTD) 29.3 
Asn450 Nδ2 
(EGF1) 
Cys473 O 
(EGF2) 26.4 
Asp393 Oδ2 
(Hybrid) 
Asn632 Nδ2 
(βTD) 22.7 
Asn452 Nδ2 
(EGF1) 
Cys473 O 
(EGF2) 21.6    
Domains are indicated in parenthesis. 
* Salt bridges. 
 
between PSI and EGF2 were unfavorable initially due to errors in structure building. 
After adjustment, the interactions became stable. Major contacts at knee were between 
EGF1 and EGF2. However, a few contacts between PSI and EGF2 including a salt bridge 
(Arg8/Glu490, Table 6.2) may be more important because all of them need to be broken 
for extension while only part of contacts between EGF1 and EGF2 need to. Other than 
the knee, the Hybrid domain contacted with EGF3, EGF4, and βTD. Most contacts were 
between Hybrid and βTD, including a salt bridge (Asp393/Arg633) that might be 
important to regulate extension. EGF4 had ~200 Å2 contacts with Hybrid, most of which 
were hydrophobic. EGF3 had much less contacts (~100 Å2) with Hybrid. Interestingly, a 
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salt bridge (Asp346/Lys676) was formed between the α7 helix of βA and the CD loop of 
βTD during equilibration, which might play a role in regulating the binding affinity of 
βA as suggested in the “dead-bolt” model [51]. 
6.3 Unbending of αVβ3 Integrin by Force 
 
Figure 6.6 Set-up of SMD simulations. A. The water box was enlarged along the vertical direction to 
provide space for αVβ3 extension. Representations are the same as in Fig. 6.3. B. The pulling force is 
loaded on the COM of Cα atoms of the central β sheet of βA while the COM of Cα atoms of βTD, 
except for loops, was restrained by a harmonic potential. 
 
 To facilitate the transition from a bent to an extended conformation, SMD 
simulations were performed. First, the previous water box used for equilibration was 
enlarged along the vertical direction in order to provide space for αVβ3 integrin extension 
(Fig. 6.6A), resulting in a system of ~850,000 atoms. In the following SMD simulations, 
a force was loaded on the COM of Cα atoms of the central β sheet of βA along the 
vertical direction, while the COM of Cα atoms of βTD, except for loops, was restrained 
by a harmonic potential. In the SMD simulations, the springs attached on pulled atoms 
moved at constant velocities, so-called constant-velocity SMD. In a fast pulling SMD 
simulation at 2 nm ns-1 with a spring constant of 1 kcal mol-1 Å-2 (695 pN nm-1), a big 
force peak was observed at ~2 nm (Fig. 6.7A). In comparison, a slow pulling SMD  
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Figure 6.7 Constant-velocity SMD simulations of αVβ3 integrin unbending. A. Plot of force versus 
extension for fast pulling with hard spring or slow pulling with soft spring. B. Plot of force versus 
extension for three slowing pulling with soft spring starting from different equilibrated conformations. 
C. Snapshots at indicated time during the first slow pulling SMD simulation. 
 
simulation was run at 2 nm ns-1 with a spring constant of 0.5 kcal mol-1 Å-2 (348 pN nm-1). 
A force peak occurred at the same location, but it is much smaller probably due to lower 
viscosity resistance. After the first peak, the force dropped to near zero, followed by 
multiple less pronounced peaks. During the pulling, simulated αVβ3 integrin was 
gradually extended as shown in Fig. 6.7C. Because slow pulling would give more time 
for the simulated structure to equilibrate so that the structure would be less distorted, two 
more constant-velocity SMD simulations were run at 2 nm ns-1. Overall, the three force-
extension curves overlapped quite well (Fig. 6.7B). A force peak of ~300 pN occurred at 
~2 nm, and then force dropped to below 100 pN. After that, multiple small peaks were  
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Figure 6.8 Critical interactions for αVβ3 integrin unbending. A. Changes of buried SASA (left y 
axis) compared with pulling force (right y axis) in the 1st slow pulling SMD. Arrows indicate force 
drops. B. Changes of number of hydrogen bonds compared with pulling force in the 1st slow pulling 
SMD. C. Interactions between Hybrid and βTD. The two residues forming a salt bridge are shown as 
spheres. Other surrounding residues are shown as sticks. D. Interactions between Hybrid and EGF4. 
Nitrogen atoms in blue, oxygen atoms in red, carbon atoms in cyan, and hydrogen atoms in white. 
 
observed. Beyond 10 nm extension, the force increased as a worm-like chain model 
because initial relaxed coiled structures were stretched after extension. During pulling, 
inter-domain contacts, especially between EGF1-4 and βTD domains of β-subunit, were 
broken. But overall, the simulated structure was not distorted badly. At end, an extended 
αVβ3 integrin with closed headpiece and closed legs were obtained. 
 The first major force peak indicated a major energy barrier that need to be 
overcome to extend αVβ3 integrin. If zoom in the first peak of the 1st slow pulling SMD, 
three force drops were observed (Fig. 6.8A). At the first drop, contact area between  
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Figure 6.9 Headpiece conformations during 1st slow pulling SMD simulation. A. Comparison of 
simulated structure at 10 ns with closed and open crystal structure. All structures were aligned with 
Cα atoms of the central β sheet of the βA domain. B. Number of hydrogen bonds between the 
protruding β-hairpin of the β-propeller domain and Hybrid domain. C. RMSD of the Hybrid domain 
from the closed or open crystal structures. D. RMSD of the Thigh domain from closed the crystal 
structure after aligned with the β-propeller domain. 
 
Hybrid and βTD decreased, indicating the breakage of their interactions. The second drop 
corresponds to the disruption of interactions between Hybrid and EGF4, shown by the 
decrease of their contact area. The third drop was mainly due to the breakage of 
interactions between Thigh and Calf1 of α-subunit. Before the second drop, force 
increased to the maximal, showing the strongest interactions to be broken during pulling. 
These interactions were between Hybrid and EGF4/βTD. Interestingly, the number of 
hydrogen bonds between Hybrid and βTD decreased from 8 to 0, but only one hydrogen 
bond existed between Hybrid and βTD before interaction breakage (Fig. 6.8B). Indeed, 
the interactions between Hybrid and βTD are mostly hydrophilic, where a salt bridge 
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(Asp393/Arg633) is surrounded by a few hydrogen bonds (Fig. 6.8C). In contrast, the 
interactions between Hybrid and EGF4 are mainly hydrophobic, involving Leu375, 
Ile380, and Leu383 on Hybrid, and Met568, Leu573, and Leu574 on EGF4 (Fig. 6.8D). 
 In the SMD simulations, the headpiece of αVβ3 integrin was still in a closed 
conformation. The two salt bridges between the β hairpin of β-propeller and hybrid were 
kept during the simulations (Fig. 6.9B), indicating a closed conformation. At ~8 ns of 1st 
slow pulling SMD, RMSD of Hybrid from the closed crystal structure decreased while 
RMSD from the open crystal structure increased (Fig. 6.9C), showing Hybrid further 
swung inward. In contrast, RMSD of Thigh increased because it swung out. The opposite 
movement of Hybrid and Thigh was because that β-subunit had longer length than α-
subunit. 
6.4 Free MD Simulations of Conformations along Unbending Pathway 
 During the unbending processes of αVβ3 integrin, different conformations were 
observed from partially to fully extended. Are these conformations stable? Are there any 
stable intermediate states? To answer these questions, free MD simulations were used to 
test the stabilities of different conformations. First, two partially extended structures were 
extracted from the two slow constant-velocity SMD simulations (Fig. 6.10). They were 
immediately after the first force peaks when the interactions between Hybrid and 
EGF4/βTD were just broken. Then, the loading force was turned off and the simulated 
integrin was allowed to move freely. Interestingly, the first partially extended structure 
(P1) from 1st SMD gradually bended back as indicated by decreasing RMSD from the 
equilibrated bent structure during the free MD simulation (Figs. 6.11 A and B). The 
RMSD went down to ~4 Å, showing that P1 structure almost returned to the bent 
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Figure 6.10 Partially extended structures for free MD simulations. Two structures were chosen 
right after the first force peak from 1st (A and B) and 2nd (C and D) slow constant-velocity SMD 
trajectories as indicated. 
 
conformation. At residue level, part of interactions was restored. Initially, the two groups 
of polar residues at Hybrid and βTD contacted with each other first, probably because 
theses residues have long sidechains and the electrostatic force are long distance 
interaction. But their contacts are not stable and frequently on and off. Compared to the 
bent structure, the distance between the COMs of sidechains of the two polar groups was 
still far away (> 10 Å) (Fig. 6.11C). Nevertheless, these interactions brought the 
headpiece and the tailpiece of β3 subunit closer, which gave chances for interactions 
between two groups of hydrophobic residues at Hybrid and EGF4. At ~7 ns, the two 
hydrophobic groups were close enough for contacts. Strong hydrophobic interactions 
brought them much closer (distance of COMs of sidechains ~5 Å). These interactions 
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Figure 6.11 Free MD simulation of the P1 structure. A. RMSD of all Cα atoms from the 
equilibrated bent structure. B. Beginning and ending P1 structures compared with the equilibrated 
structure. Structures were aligned with EGF4, βTD, and Calf2. C. Distances between sidechain COMs 
of groups of interacting residues: polar residues at Hybrid and βTD, nonpolar residues at Hybrid and 
EGF4, and a salt bridge (Asp363/Arg633) between Hybrid and βTD. D. Beginning and ending 
structures at Hybrid/EGF4/ βTD interface. Basic residues are in blue, acidic residues in red, polar 
residues in green, and nonpolar in white. 
 
were stable during the later 10 ns simulation and helped stabilize the bent conformation. 
 A similar free MD simulation was performed for the second partially extended 
structure (P2) from 2nd SMD. The headpiece of P2 also moved toward the tailpiece, 
indicated by decreasing RMSD from the equilibrated bent structure (Fig. 6.12A). 
However, the RMSD fluctuated between 6 and 8 Å, larger than that of P1, showing it was 
less close to the bent structure. Indeed, neither polar nor nonpolar interactions were 
restored as shown by large distances between COMs of sidechains (> 10 Å) (Fig. 6.12C). 
Although some polar residues at Hybrid and βTD were observed to contact frequently 
with each other, the distance between the two hydrophobic groups was still too far to get 
contacts. This was probably because a twist of the headpiece relative to the tailpiece, 
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Figure 6.12 Free MD simulation of the P2 structure. A. RMSD of all Cα atoms from the 
equilibrated bent structure. B. Beginning and ending P1 structures compared with the equilibrated 
structure. Structures were aligned with EGF4, βTD, and Calf2. C. Distances between sidechain COMs 
of groups of interacting residues: polar residues at Hybrid and βTD, nonpolar residues at Hybrid and 
EGF4, and a salt bridge (Asp363/Arg633) between Hybrid and βTD. D. Beginning and ending 
structures at Hybrid/EGF4/ βTD interface. Basic residues are in blue, acidic residues in red, polar 
residues in green, and nonpolar in white. 
 
induced by either different starting conditions or restraint on βTD that was not used for 
P1. 
 According to the above free MD simulations, a partially extended conformation 
tends to bend back because further extension costs more energy. Will a fully extended 
conformation bend back or be stable? Two fully extended structures were extracted from 
1st and 2nd slow constant-velocity SMD simulations as shown in Fig. 6.13. As mentioned 
before, the fully extended structures still had a closed headpiece and closed legs. The first 
fully extended structure (E1) from 1st SMD became relaxed after the loading force was 
released. The RMSD from the initial structure first decreased and then reached a plateau 
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Figure 6.13 Fully extended structures for free MD simulations. Two fully extended structures were 
chosen at indicated time from 1st (A and B) and 2nd (C and D) slow constant-velocity SMD trajectories. 
 
 (Fig. 6.14A), indicating the conformation was stable in the 20 ns free MD simulation. At 
the end of the simulation, E1 was still extended but curved (Fig. 6.14A). What are 
interactions that contributed to stabilize the extended conformation? Some new 
interactions at α-genu, which did not exist in the bent structure, were formed for the 
extended structure. Asp457 of Thigh became close to and coordinated with Ca2+ at α-
genu (Fig. 6.14D). This coordination was very stable and kept in the last 15 ns, indicated 
by a small distance (< 4 Å) between Oδ atoms of Asp457 and Ca2+ (Fig. 6.14C). Because 
the Ca2+ also coordinated with Glu636 of Calf1 domain, Asp457-Ca2+-Glu636 formed a 
bridge between Thigh and Calf1 to stabilize the extended conformation. Besides, salt 
bridges between Lys688 of Calf1 and Glu545 of Thigh or between Lys688 of Calf1 and 
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Figure 6.14 Free MD simulation of the E1 structure. A. RMSD of all Cα atoms from the 
equilibrated bent structure or the initial extended structure. B. Ending E1 structure. Right one was 
rotated 90 degree around the vertical axis. C. Distances between three pairs of residues during free 
MD of E1: Oδ atoms of Asp457 and Ca2+ at α-genu, Oε atoms of Glu545 and Nζ atom of Lys688, and 
Oδ atoms of Asp595 and Nζ atom of Lys688. D. Ending structure of free MD of E1 at Thigh/Calf1 
interface. Nitrogen atoms in blue, oxygen atoms in red, carbon atoms in cyan, and hydrogen atoms in 
white. E. Distances between three pairs of residues during equilibration of the bent αVβ3. F. Ending 
structure of equilibration of the bent αVβ3 at Thigh/Calf1 interface. 
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Glu595 at the linker were formed, although they were not so stable and fluctuated. The 
salt bridges might also stabilize the extended conformation. These new interactions did 
not exist in the equilibrated bent structure (Fig. 6.14F). Indeed, Asp457 was quite far 
away from Ca2+ (> 10 Å) (Fig. 6.14E). The distance between Oε atoms of Glu545 and Nζ 
atom of Lys688 was also too large to form salt bridge during equilibration of the bent 
structure. Only Asp595 sometimes got close to Lys688 to form a salt bridge, but much 
less frequently. 
 
Figure 6.15 Free MD simulation of the E2 structure. A. RMSD of all Cα atoms from the 
equilibrated bent structure or the initial extended structure. B. Ending E2 structure. Right one was 
rotated 90 degree around the vertical axis. C. Distances between three pairs of residues during free 
MD of E2: Oδ atoms of Asp457 and Ca2+ at α-genu, Oε atoms of Glu545 and Nζ atom of Lys688, and 
Oδ atoms of Asp595 and Nζ atom of Lys688. D. Ending structure of free MD of E1 at Thigh/Calf1 
interface. Nitrogen atoms in blue, oxygen atoms in red, carbon atoms in cyan, and hydrogen atoms in 
white.  
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 Similarly, a free MD was performed for the second fully extended structure (E2) 
from 2nd SMD. E2 was also stable and kept in an extended conformation in 20 ns. At end, 
E2 was extended but curved (Fig. 6.15B). Differently, Asp457 initially fluctuated around 
and did not have stable coordination with Ca2+ at α-genu. Until 20 ns, the distance 
between Oδ atoms of Asp457 and Ca2+ decreased to below 4 Å and then the coordination 
became stable (Fig. 6.15C). The interactions between Lys688 and Glu545/Asp595 were 
seldom observed during the simulation. The difference between free MD simulation of 
E1 and E2 demonstrated the effects of initial conditions. Nevertheless, both simulations 
showed the probably important role of Asp457 in stabilizing the extended conformation. 
6.5 Separation of the Lower Legs of αVβ3 Integrin by Force 
 In the switchblade model [50], it was suggested that separation of lower legs of 
integrins would induce integrin extension and further swing-out of the Hybrid domain to 
bring the βA domain into a high affinity state for ligands during an inside-out signaling. 
To test this model, the lower legs of simulated αVβ3 integrin were separated by a force in 
constant-velocity SMD simulations. A force was loaded on the COM of Cα atoms of 
βTD, except for loops, and pointed along the horizontal direction (Fig. 6.16A). At the 
same time, the COM of Cα atoms of β-sheet of Calf2 was restrained by a harmonic 
potential. Two SMD simulations were run with different pulling speed and spring 
constant. A big force peak was observed at ~2 nm extension in both simulations (Fig. 
6.16B). Compared to the unbending SMD in section 6.3, the peak force of leg separation 
was almost two folds of that of unbending at the same pulling speed of 2 nm ns-1, which 
indicated that leg separation was much harder than unbending. After the big force peak, 
two lower legs of the simulated integrin gradually separated as shown in Fig. 6.16C. At 
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Figure 6.16 SMD simulations for separation of lower legs of αVβ3 integrin. A. A force was loaded 
on βTD while Calf2 was restrained. α-subunit in cyan, headpiece of β-subunit in pink, and tailpiece of 
β-subunit in iceblue. B. Force vs. extension curves for two SMD simulations with different pulling 
velocity and spring constant. C. Snapshots of simulated structures at indicated time during the 
simulation with 2 nm ns-1 pulling velocity. 
 
end, the lower legs were fully separated to an extension of ~10 nm, but part of 
interactions between α- and β-subunit at the genu and most of interactions between the 
headpiece and the tailpiece of β-subunit still existed. 
 The big force peak corresponded to the disruption of interactions between 
domains of lower legs as indicated by sudden drops of their contact areas (Figs. 6.17 A 
and B). Interactions between Calf2 and EGF4/β-ankle/βTD were first broken so that 
force started to drop. But interactions between Calf2 and EGF3 were still held and kept 
the force at a high level. Until these interactions are broken, the force decreased greatly. 
In contrast, Thigh/EGF2 contact area initially increased when the force dropped. When 
the legs separated quite far away, the Thigh/EGF2 contact area had a sudden drop. The  
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Figure 6.17 Changes of interactions during leg separation with a pulling speed of 2 nm ns-1. 
Buried SASAs between α- and β-subunits for each domains of α-subunit (A) or β-subunit (B) were 
plotted versus simulation time. Number of hydrogen bonds that formed between α- and β-subunits for 
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each domains of α-subunit (C) or β-subunit (D) were plotted versus simulation time. Structures of 
critical salt bridges (E) or hydrophobic interactions (F) between Calf2 and βTD. G. Hydrophobic 
interactions between Calf2 and β-ankle. H. Interactions between Calf1 and EGF3. 
 
numbers of hydrogen bonds that formed between α- and β-subunits changed similarly as 
buried SASAs (Figs. 6.17 C and D). However, the changes of hydrogen bond number 
were not as big as expected, showing a large portion of interactions was probably 
hydrophobic. Indeed, both hydrophilic and hydrophobic interactions were found between 
the lower legs. Two salt bridges (Glu770/Lys650 and Glu769/Lys646) existed between 
Calf2 and βTD (Fig. 6.17E). At the same time, several hydrophobic residues of Calf2 and 
βTD also contacted with each other (Fig. 6.17F). Similarly, Pro602 and Thr603 of β-
ankle inserted into a hydrophobic core formed by several hydrophobic residues of Calf2 
(Fig. 6.17G). Between Calf1 and EGF3, salt bridges, hydrogen bonds, and hydrophobic 
interactions all existed (Fig. 6.17H). Compared to the interactions between the headpiece 
and the tailpiece, the interactions between the lower legs are much more extensive, 
therefore leg separation required higher force (or more energy) than unbending. 
 Before simulations of unbending of integrins with separated legs, the final 
structure obtained from the separation SMD simulation was equilibrated for 10 ns in 
order to reduce distortion due to nonequilibrium force pulling. The RMSD of all Cα 
atoms from the initial structure increased and then reach a plateau (Fig. 6.18A), 
indicating the system arrived in equilibrium. During equilibration, Thigh/Calf1 contacts 
decreased (Fig. 6.18D), but hydrogen bonds between them did not decrease (Fig. 6.18B), 
showing most of lost contacts were hydrophobic. Interactions between PSI and EGF2 
increased (Fig. 6.18E), the same did contacts between Hybrid and EGF3/EGF4 (Fig. 
6.18F). The changes of number of hydrogen bonds were small, showing at least part of  
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Figure 6.18 Equilibration of the bent αVβ3 integrin with separated lower legs. A. RMSD of all Cα 
atoms from the initial structure. Number of hydrogen bonds were plotted versus equilibration time for 
the knee region (B) or other regions (C). Buried SASAs between the headpiece and the tailpiece were 
plotted versus equilibration time for domains in α-subunit (D), the knee of β-subunit (E), or the head 
and the leg of β-subunit (F). 
 
changes of contacts was hydrophobic. 
6.6 Unbending of αVβ3 Integrin with Separated Lower Legs 
 Starting from different equilibrated structures of αVβ3 Integrin with separated 
lower legs, three SMD simulations (SMD4-6) were performed. A force was loaded on Cα 
atoms of the βA domain while Cα atoms of βTD and Calf2, except for loops, were 
restrained (Fig. 6.19A). The attached spring moved along the vertical direction at a speed 
of 2 nm ns-1 with a force constant of 0.5 kcal mol-1 A-2. The force-extension curves of the 
three SMD simulations overlapped well (Fig. 6.19B). Similar to previous unbending of 
αVβ3 integrin with closed legs, a big force peak occurred at ~2 nm. Differently, two other 
peaks were observed, indicating more resistance during unbending. As shown in Fig. 
6.19C, αVβ3 integrin gradually stood up. The interactions at the knee were broken, but the 
Hybrid domain still kept closed. 
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Figure 6.19 SMD simulations of unbending of αVβ3 integrin with separated lower legs. A. Set-up 
for SMD simulations. Force was loaded on βA while restraints were on βTD and Calf2. B. Force vs. 
extension curves for three SMD simulations (SMD4-6) with a pulling speed of 2 nm ns-1. Three major 
force peaks were labeled with numbers. C. Snapshots at indicated time during SMD4. 
 
 Comparison between force and contact areas showed that each force peak 
corresponded to a breakage of contacts between domains of β-subunit (Fig. 6.20A). The 
breakage of interactions at Hybrid/βTD/EGF4 interfaces caused the first force drop. Then, 
the loss of contacts at Hybrid/EGF3 interface resulted in the second force drop. After that, 
EGF3 formed some interactions with PSI, indicated by increased buried SASA. Finally, 
the disruption of contacts at PSI/EGF1/EGF2 interfaces induced the third force drop. Part 
of broken interactions included hydrogen bonding as shown by drops of number of 
hydrogen bonds (Fig. 6.20B), except for EGF4/Hybrid contacts, which are mainly 
hydrophobic. The last two force peaks were not seen in the unbending with closed legs 
but pronounced with separated legs because the leg separation released constraints on the 
lower leg of β-subunit and thus resulted in more contacts between the headpiece and the 
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Figure 6.20 Critical interactions for αVβ3 integrin unbending with separated lower legs. A. 
Buried SASAs between the headpiece and the tailpiece of β-subunit for each domain. Arrows indicate 
sudden drops of contact areas. B. Changes of numbers of hydrogen bonds between the headpiece and 
the tailpiece of β-subunit for each domain. Arrows indicate sudden drops. Interacting residues 
between Hybrid and EGF3 of αVβ3 integrin with separated legs (C), which did not contact with each 
other in αVβ3 integrin with closed legs (D). 
 
tailpiece of β-subunit. For example, several new interactions between Hybrid and EGF3, 
including a salt bridge, hydrogen bonds, and hydrophobic interactions, were formed when 
the legs were separated, but did not exist when the legs were closed (Figs. 6.20 C and D). 
 As mentioned above, the Hybrid domain did not swing out although the 
interactions at the knee were broken (Fig. 6.21A). The hydrogen bonding between the 
protruding β-hairpin of the β-propeller domain and Hybrid domain existed during the 
pulling (Fig. 6.21B), indicating that Hybrid kept closed. The RMSD of Hybrid from the 
closed or the open crystal structure, aligned with the central β-sheet of βA, did not 
change much, which also showed Hybrid was still closed (Fig. 6.21C). However, Hybrid  
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Figure 6.21 Headpiece conformations during the SMD4 simulation with separated lower legs. A. 
Comparison of simulated structure at 10 ns with closed and open crystal structure. All structures were 
aligned with Cα atoms of the central β-sheet of the βA domain. B. Number of hydrogen bonds 
between the protruding β-hairpin of the β-propeller domain and Hybrid domain. C. RMSD of the 
Hybrid domain from the closed or open crystal structures. D. RMSD of the Thigh domain from closed 
the crystal structure after aligned with the β-propeller domain. 
 
did not swing further in as seen in previous SMD simulations with closed legs probably 
because leg separation indeed changed force exerted on two subunits. This was also 
demonstrated by much larger swing-out of the Thigh domain (Fig. 6.21D). 
6.7 Free MD Simulations of Conformations with Separated Legs 
 Here, different conformations of αVβ3 integrin with separated legs along its 
unbending pathway were tested for their stabilities. First, a partially extended structure 
(P3) immediately after the first force drop was used for a free MD simulation (Fig. 
6.22B). In the starting structure of P3, contacts between Hybrid and EGF4/βTD were  
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Figure 6.22 Free MD simulation of the P3 structure. A. Starting P3 structure. Right one was rotated 
90 degree around the vertical axis. B. The starting P3 structure was chosen at indicate location right 
after the first force drop. C. RMSD of all Cα atoms from the equilibrated bent structure or the initial 
P3 structure. D. Comparison between P3 and bent structures at starting and ending time of the free 
MD simulation. E. Distances between sidechain COMs of groups of interacting residues in the bent 
structure: polar residues at Hybrid and βTD, nonpolar residues at Hybrid and EGF4, and a salt bridge 
(Asp363/Arg633) between Hybrid and βTD. F. Beginning and ending structures at 
Hybrid/EGF4/ βTD interface. Basic residues are in blue, acidic residues in red, polar residues in green, 
and nonpolar in white. 
 
already broken, but EGF3 still interacted with Hybrid (Fig. 6.22A). During the free MD, 
RMSD from the equilibrated bent structure with separated legs decreased (Fig. 6.22C). 
But it was still large in the end (~ 10 Å), indicating P3 did not return to the bent structure 
as seen in close leg simulations. Indeed, P3 was still in a partially extended conformation 
(Fig. 6.22D). The interactions at Hybrid/EGF4/βTD, which existed in the bent structure,  
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Figure 6.23 Free MD simulation of the P4 structure. A. Starting P4 structure. Right one was rotated 
90 degree around the vertical axis. B. The starting P4 structure was chosen at indicate location right 
after the second force drop. C. RMSD of all Cα atoms from the equilibrated bent structure or the 
initial P4 structure. D. Comparison between P4 and bent structures at starting and ending time of the 
free MD simulation. E. Beginning and ending structures at Hybrid/EGF3 interface. Basic residues are 
in blue, acidic residues in red, polar residues in green, and nonpolar in white. 
 
were not restored at all (Figs. 6.22 E and F).  
A second partially extended conformation with separated legs (P4) was selected 
right after the second force drop (Fig. 6.23B). In the beginning structure of P4, 
interactions at the Hybrid/EGF3 interface were also disrupted (Fig. 6.23A). After force 
release, P4 tended to bend back, indicated by decreasing RMSD from the bent structure  
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Figure 6.24 Free MD simulation of the E3 structure. A. Starting E3 structure. Right one was 
rotated 90 degree around the vertical axis. B. The starting E3 structure was chosen at indicate location 
when αVβ3 integrin was fully extended. C. RMSD of all Cα atoms from the equilibrated bent structure 
or the initial E3 structure. D. Comparison between E3 and bent structures at starting and ending time 
of the free MD simulation. E. Distances between three pairs of residues during free MD of E3: Oδ 
atoms of Asp457 and Ca2+ at α-genu, Oε atoms of Glu545 and Nζ atom of Lys688, and Oδ atoms of 
Asp595 and Nζ atom of Lys688. F. Starting and ending structures of E3 at Thigh/Calf1 interface. 
 
(Fig. 6.23C). However, P4 did not move close to the bent structure, shown by a larger 
RMSD than P3 (~ 20 Å). Similarly, broken interactions at the Hybrid/EGF3 interface did 
not restore (Fig. 6.23E). 
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 Finally, a fully extended structure (E3) was extracted from the SMD4 trajectory 
(Fig. 6.24B). At the beginning, E3 was fully straight and most of interactions between the 
headpiece and the tailpiece were broken (Fig. 6.24A). During the free MD, E3 moved 
toward the bent conformation as indicated by decreasing RMSD from the bent structure, 
although RMSD was still large (~30 Å) (Fig. 6.24C). At the end of the free MD, E3 
became a partially extended conformation (Fig. 6.24D). Some interactions were formed 
at the knee, but most of broken interactions between the headpiece and the tailpiece were 
not restored. In the previous free MD simulation for E1/E2 with closed legs, the fully 
extended structures were stable and salt bridges and calcium coordination at α-genu 
contributed to the stability. Consistently, Asp457-Ca2+ coordination and Glu545-Lys688 
salt bridge were not observed during the entire free MD simulation for E3 so that the 
extended conformation with separated legs is not stable (Figs. 6.24 E and F). 
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CHAPTER 7  
DISCUSSION 
7.1 Glycosylation Effects on CD16-IgG Binding 
 In chapter 4, MD simulations and the MM-PB/GBSA method were applied to 
study the structural basis for glycosylation effects on CD16-IgG binding. The results 
showed that glycosylation of CD16 indeed changed the conformation of the CD16-IgG 
complex and thus their binding due to the interactions between carbohydrate chains 
attached on protein cores. The studies provide a structural mechanism how glycosylation 
regulates CD16-IgG binding affinity and offer insights into the molecular basis for the 
important roles of glycosylation in immune systems. 
 CD16 is a heavily glycosylated receptor expressed on immune cells and links the 
humoral to the cellular immune responses. Important roles of glycosylation of CD16 have 
been demonstrated by previous studies [4, 7] and the studies of our group (Ning Jiang, 
unpublished). The crystal structure of the CD16-IgG complex [5] provides insights into 
the effects of glycosylation on CD16-IgG binding. But no sugars are on the CD16 in the 
crystal structure, so it is still a mystery how glycosylation modulates CD16-IgG binding. 
In order to model a glycosylated CD16-IgG complex, an N-glycan core was added in 
silico to one of N-glycosylation sites of CD16, which locates at the binding pocket (Fig. 
4.1). In the free MD simulation of the unglycosylated CD16-IgG complex, Cγ2 domains 
had quite large fluctuations around the Cγ2/3 junctions and showed the flexibility of IgG 
Fc (Fig. 4.2), which was not appreciated by looking at the static crystal structure. The 
flexibility of IgG Fc may be important for modulation of CD16-IgG binding. The two 
carbohydrate chains on IgG Fc were interacting with each other, which suggest that 
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sugars may not only act as spacers but also keep the integrity of the IgG Fc structure. 
After adding sugars to CD16, a global conformational change was observed. CD16 was 
shifted towards the Cγ2-B domain, Cγ2-B became more open, and Cγ2-A became more 
closed (Fig. 4.5C). The conformational changes were caused by interactions between 
sugars on CD16 and Cγ2-B of IgG (Fig. 4.6). Particularly, the Fucose residue of the sugar 
on Cγ2-B was mainly involved in interactions with the sugar on CD16. Indeed, the 
removal of this Fucose residue increases 3D affinity by over one order of magnitude [86]. 
As a result of the conformational changes, the binding pocket between CD16 and IgG Fc 
was largely modified. In the unglycosylated complex, contact areas between CD16 and 
IgG Fc were almost evenly distributed on Cγ2-A and Cγ2-B. After the conformational 
changes, contacts at the CD16/Cγ2-A interface were less while contacts at the CD16/Cγ2-
A interface became more (Figs. 4.4 and 4.7).The number of hydrogen bonds between 
CD16 and Cγ2-A decreased greatly. Most of lost hydrogen bonds involve residues of the 
lower hinge of Cγ2-A (Table 4.1). This region was shown experimentally to be critical 
for CD16-IgG binding by previous studies. Therefore, the observed changes of the 
binding pocket suggest that the affinity of CD16-IgG binding may be decreased upon the 
glycosylation of CD16. 
 To quantitatively evaluate the changes of the CD16-IgG, MM-PB/GBSA was 
used to calculate the binding free energy of the CD16-IgG complexes. Comparison 
between the computational and experimental results showed the PB method gave a better 
estimate than the GB method (Fig. 4.9), which is reasonable because GB is an 
approximation of PB. Although the difference of 4 kcal mol-1 is still much higher than the 
chemical accuracy (1 kcal mol-1), it is not bad considering relative cheap computation for 
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MM-PB/GBSA. However, PB and GB gave opposite results for comparison between the 
unglycosylated and glycosylated CD16 probably because the limit of sampling time and 
also the large error brought in by solute entropy calculation. Calculation of vibrational 
entropy by normal mode analysis is always very computational expensive, so much less 
samples were used, resulting in large error bars. These results show that it is difficult for 
MM-PB/GBSA to predict a small free energy difference of <10 kcal mol-1. When the 
entropy part was excluded, both PB and GB showed less negative effective energy upon 
CD16 glycosylation. Decomposition of the effective energy on each residue revealed 
critical residues for CD16-IgG binding (Fig. 4.10). Same as seen in the structural analysis, 
the contribution from residues of Cγ2-A was largely decreased while that from residues 
of Cγ2-B was increased. Although it cannot give an accurate number of binding free 
energy, MM-PB/GBSA is really a powerfully tool to identify “hot-spots” in protein-
protien interactions. 
 Another interesting thing was found in this study is that CD16 transitioned from 
the conformation in the complex crystal structure to the conformation in the stand-alone 
crystal structure. A transition state was observed, which is quite far from both 
conformations in the crystal structure. This observation demonstrates that the transition 
between two states generally does not follow a shortest distance pathway. Instead, the 
transition follows a pathway with the lowest energy cost, which may need a long distance 
movement. Furthermore, the transition was correlated well with residue Trp95 flipping, 
which is also seen in the crystal structure. So the conformational transition is probably 
controlled by the interactions between Tyr14 and Trp95. Either in crystals or in 
simulations, CD16 is a soluble form. When it is on membrane with a certain anchor, will 
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CD16 favors a certain conformation or amplifies the conformational change, and thus 
induces changes of affinity for IgG? Probably this could be an explanation of anchor 
effects on CD16-IgG binding observed in experiments [3]. 
7.2 Unfolding of the VWF A Domains 
 In chapter 5, MD simulations were used to study the unfolding mechanism of  the 
VWF A1 and A2 domains by tensile force or under high temperature. The results showed 
how A1 and A2 were unfolded, providing the structural basis for VWF A domain 
stabilities and insights into the mechanism of the ADAMTS-13 cleavage of the A2 
domain.  
First, SMD was applied to simulate the forced unfolding of the VWF A1 and A2 
domains. The unfolding of the A2 domain always started from the C-terminus and 
followed the same pathway no matter which terminus was pulled (Figs. 5.2 and 5.3). The 
sequential pullouts of the β-strands from the protein core generated sawtooth-like peaks 
in the force-extension curves, indicating that the central β-sheet was the most difficult to 
be unfolded by tensile force. Before unfolding, the proteolytic site for ADAMTS-13 
cleavage was completely buried inside the A2 domain. After unfolding started, the 
sidechain of the proteolytic site began to expose. However, the backbone of the 
proteolytic site was not exposed until its neighboring β5 strand was pulled out. By 
comparison, the A1 domain was pulled at the C-terminus with or without its disulfide 
bond, which links its N- and C-termini. With the intact disulfide bond, the force could not 
propagate into the core of the A1 domain so that the core was not affected at all (Fig. 
5.4). When the disulfide bond was broken in silico to mimic reducing conditions, the A1 
domain was unfolded along a pathway similar to that of the A2 domain (Fig. 5.5).  
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Figure 7.1 Comparison between simulations and experiments for forced unfolding of the VWF 
A2 domain. A. Plot of force vs. extension during the simulation of the A2 unfolding by force (replot 
of Fig. 5.2B). B. Plot of force vs. extension for the GPIb-A1A2A3 binding in one AFM experiment. 
Scatters are experimental data and curves are fitting by the worm-like chain model. C. Distribution of 
length increment due to structural failure observed in AFM experiments. Data in B and C are provided 
by Tao Wu and Jiangguo Lin. 
 
The sawtooth-like force peak pattern (Fig. 7.1A) in the simulations of the VWF A 
domains unfolding is actually observed in force-ramping AFM experiments for the GPIb-
A1A2A3 binding (Tao Wu et al., unpublished), where GPIb was adsorbed on AFM tips 
while an A1A2A3 triplet was coated on petri dishes. Multiple force peaks occurred. In 
the two-peak case as shown in Fig. 7.1B, the first force drop is due to certain structural 
failure and the second drop corresponds to the dissociation of the GPIb-A1A2A3 bond. 
By fitting the experimental data with the worm-like chain model, the difference between 
the contour lengths of the two force peaks indicates the length increment due to the 
structural failure. The length increment spans from 10 nm to 80 nm (Fig. 7.1C). The 
structural failure could be the breakage of inter-domain interactions among the three A 
domains or the unfolding of the A2 domain. If the structural failure is the A2 unfolding, 
the majority could not be the pullout of a single β strand because it generates only 10 nm 
length increment. Instead, it could be partial or full unfolding of A2. Considering the C-
terminal portion of A2 is unfolded (first three peaks in Fig. 7.1A), the length increment is 
20-30 nm, which corresponds to the first peak of the distribution in Fig. 7.1C. On the 
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other hand, when A2 is fully unfolded, the length increment is 50-60 nm, which 
corresponds to the second peak of the distribution.   
It was further demonstrated that the specific topology of the A domains 
determines the sequential order of the pullouts of the β strands (Fig. 5.6). The N-terminal 
β1 strand is in the middle of the β sheet with many hydrogen bonds, while the C-terminal 
β6 strand is on the edge of the β sheet with only a few hydrogen bonds. Therefore, the C-
terminus is much easier to be pulled out than the N-terminus. Moreover, the major 
resistance of the A1 and A2 domains to unfolding by tensile force came from the 
hydrogen network of the central β-sheet (Fig. 5.7). Two different unfolding pathways of 
β strands were observed: sliding and unzipping pathways. Unfolding along the former 
pathway would encounter a much higher energy barrier than the latter pathway (Fig. 5.8). 
Although the A1 and A2 domains unfolded quite similarly in terms of the pullouts of the 
β strands, they differed in the unfolding of their helices (Fig. 5.9). 
 The A2 domain hosts the proteolytic site for ADAMTS-13 while the A1 domain 
provides binding sites for GPIb [13, 14] and collagen [15]. Because the proteolytic site in 
the A2 domain is completely buried, the A2 domain should be easy to unfold to expose 
the proteolytic site in vivo for VWF to be cleaved. In contrast, the binding site for GPIb is 
on the surface of the N-terminal portion of the A1 domain (β3 side), so the A1 domain 
should be stable and not easy to unfold. Indeed, the GPIb-A1 complex structure shows 
little changes of the A1 domain upon binding [14]. The MD simulations demonstrate the 
importance of the disulfide bond in enhancing the A1 domain stability (Fig. 5.4B). The 
A2 domain does not have a disulfide bond, which makes it relatively easy to unfold. 
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 The SMD simulations showed that the proteolytic site of the A2 domain was 
exposed step-by-step from fully buried to fully exposed (Figs. 5.2C and 5.3C). At what 
stage can ADAMTS-13 access and cleave the proteolytic site? The crystal structures of 
the catalytic domains of several ADAMTS family members, including ADAMTS-1, 4, 
and 5, were solved recently [87-89]. The active site locates at a shallow cleft on the 
surface of the catalytic domain, which may fit a single β strand. If that is the case, one 
side or all of the backbone of the β4 strand, where the proteolytic site is, needs to be 
exposed so that the β4 strand can get into the cleft of ADAMTS-13. Therefore, the A2 
domain needs to be partially or fully unfolded for cleavage to occur under physiological 
condition. Could any intermediate states exist during the unfolding of the A2 domain? 
The pullouts of β5 and β4 generated the highest force peaks (Figs. 5.2B and 5.3B), 
showing largest energy barriers on the unfolding pathway. One intermediate between 
these two energy barriers could exist, in which one side of the backbone of the β4 strand 
is exposed. Further computational and experimental studies are required to reveal this 
possible intermediate state. Nevertheless, unfolding of the A2 domain is required for 
proteolysis by ADAMTS-13, making A2 a potential mechanosensor: only when a tensile 
force is above a certain threshold would the A2 domain be unfolded and cleaved by 
ADAMTS-13. 
 In the simulations of thermal unfolding of the A1 and A2 domains, the 
temperature was increased to 500 K and then the pressure was adjusted to 1 atm (Figs. 
5.11A and 5.12A). After releasing restraints on the proteins, stepwise unfolding was 
observed in terms of RMSD from the starting structures (Figs. 5.11C and 5.12C). The C-
terminal portion of the A2 domain was most susceptible to thermal unfolding. During the 
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46 ns simulation, the α7, α6 helices, and β6 strand were unfolded into loops and flipped 
away from their original position (Fig. 5.11E), so the sidechain of the proteolytic site was 
partially exposed (Fig. 5.11D). Meanwhile, part of the α5-loop was converted to a helix. 
In contrast, the N-terminal portion of the A1 domain was easier to be unfolded by thermal 
forces. During the 30 ns simulation, the β3 strand was disconnected from the β-sheet and 
converted to a helix. Then the β3 and α3 helices flipped upward away from their original 
position (Fig. 5.12D). At the same time, the α4 helix was unfolded to a loop. On the C-
terminal portion of the A1 domain, the β6 strand was also converted to a helix while the 
β7 helix was broken into two parts.  The thermal unfolding of the A1 and A2 domains 
was very different from the unfolding by tensile force, reflecting the different ways that 
tensile force and thermal force act on the proteins.  
 In the thermal unfolding simulations, the proteolytic site of A2 was only partially 
exposed. As discussed above, ADAMTS-13 may not be able to access the proteolytic site 
at this stage. It could be imagined that the whole domain can fall apart if simulations are 
run longer. Then the proteolytic site is mostly exposed for ADAMTS-13 cleavage. 
7.3 Unbending of αVβ3 Integrin 
 In chapter 6, the unbending of αVβ3 integrin from a bent to an extended 
conformation was simulated by SMD. Critical residues that regulate the unbending were 
identified. Furthermore, the stabilities of different conformations along the unbending 
pathway were tested. The study suggests the structural basis for the transition between 
different conformations and provides insights into the mechanism of regulation of 
integrin functions through global conformational changes. 
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 Global conformational changes of integrins are thought to be directly related to 
regulation of integrin funcions as suggested in the switchblade model [45, 47, 50]. 
Starting from the crystal structure of the αVβ3 ectodomain, which was the only available 
structure of the full integrin ectodomain at the time of the study, homology models of the 
two unresolved EGF1/2 domains were built based on the β2 subunit structure to obtain a 
complete ectodomain structure for simulations. It turns out that the homology models are 
not bad. Compared to the recent published crystal structure of αVβ3 ectodomain [46], the 
location and the overall structure and conformation of the models are similar. 
 In SMD simulations, the βA domain was pulled by a force while the βTD domain 
was restrained. Very nicely, the simulated integrin became extended gradually (Fig. 6.7). 
A major force peak was observed, corresponded to the breakage of interactions at 
Hybrid/EGF4 and Hybrid/βTD interfaces (Fig. 6.8). Interestingly, the interactions 
between Hybrid and βTD are mainly hydrophilic, including a salt bridge Asp393/Arg633. 
The importance of residue Arg633 was recognized by Matsumoto et al. [90], although the 
salt bridge was not mentioned. In contrast, the interactions between Hybrid and EGF4 are 
mostly hydrophobic. The importance of these interactions was further emphasized by free 
MD simulations of a partially extended conformation. During the free MD, the 
hydrophilic residues at Hybrid and βTD first contacted with each other, and then the 
hydrophobic interactions between Hybrid and EGF4 stabilized the bent conformation 
(Fig. 6.11).  
 In the constant-velocity SMD simulations, the length increase after the first force 
drop due to the breakage of interactions at the Hybrid/EGF4/βTD interfaces is ~5 nm 
(Fig. 7.1A). In the AFM experiments for the α5β1 integrin-Fibronectin binding (Fang  
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Figure 7.2 Comparison between simulations and experiments for unbending of integrin with 
constant-velocity pulling. A. Plot of force vs. extension during constant-velocity SMD simulations 
(replot of Fig. 6.7B). B. Plot of force vs. extension for the α5β1 integrin-Fibronectin binding during 
one AFM experiment. Blue color indicates the force loading phase while red color shows the force 
releasing phase. C. Distribution of length decrease observed in AFM experiments. Data in B and C are 
provided by Kong Fang. 
 
Kong, unpublished), where the cantilever first moves up at a constant speed (force 
loading phase) and then goes down at another constant speed (force releasing phase), a 
sudden length change is also observed (Fig. 7.1B). The distribution of the length decrease 
has a maximum at ~5 nm, similar to that in simulations. The legless α5β1 integrin does 
not have the sudden length change (data not shown), therefore the change is most likely 
because of the breakage (or restoration) of interactions at the Hybrid/EGF4/βTD 
interfaces during unbending (or rebending). The full extension of αVβ3 integrin results in 
a length increase of ~15 nm, which is also shown in a constant-force (200 pN) SMD 
simulation (Fig. 7.3A). Indeed, when the pulling force is kept at a constant level in 
biomembrane force probe (BFP) experiments for the αLβ2 integrin-ICAM1 binding (Wei 
Jack Chen, unpublished), a sudden length increase was observed (Fig. 7.3B). The 
distribution of length increment has a maximum at ~17 nm (Fig. 7.3C). Since αLβ2 has an 
additional αA domain, it is reasonable that αLβ2 has a bigger extension than αVβ3. The 
consistence of simulation observation with experiments justifies the simulation results 
and also provides structural explanation for experimental data. 
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Figure 7.3 Comparison between simulations and experiments for unbending of integrin under 
constant force. A. Plot of distance between the βA and βTD domains vs. simulation time during a 
constant-force (200 pN) SMD simulation of αVβ3 integrin. B. Plot of displacement vs. time for the 
αLβ2 integrin-ICAM1 binding during one BFP experiment. C. Distribution of length increment 
observed in BFP experiments. Data in B and C are provided by Wei Jack Chen. 
 
After the extension of simulated αVβ3 integrin, the Hybrid domain did not swing 
out and the leg did not separate. So extension only is not enough for Hybrid swing-out or 
leg separation. Probably, they are not coupled. There were no ligands in the simulated 
integrin. One would think maybe ligands could make Hybrid swing-out or leg separation. 
However, after extension, the interactions between the legs are mostly kept. That means 
Hybrid swing-out or leg separation is not easier after extension. Could force help it? In 
the SMD simulations, the force was along the extension direction (i.e., normal to the 
imaginary cell membrane). The force did not induce Hybrid swing-out. Instead, it made 
Hybrid even swing-in after the integrin was fully stretched (Fig. 6.9). This is the same as 
what Zhu et al. found [46]. Only if there is another force parallel to the cell membrane, 
the legs can be separated and Hybrid can swing out. 
 After fully extension of simulated integrin, free MD simulations were run to test 
its stability. In two simulations, the extended conformation was stable during 20 ns (Figs. 
6.14 and 6.15). Two new interactions were identified at α-genu. One is that residue 
Asp457 of the Thigh domain coordinated with the Ca2+ ion at α-genu. The other is that 
Glu545 of Thigh formed a salt bridge with Lys688 of Calf1. These two interactions 
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bridged Thigh and Calf1 together and thus stabilized the extended conformation. This 
provides an explanation for how metal ions regulate integrin conformation. Maybe 
different metal ions have different abilities to form new coordination with Asp457. Mn2+ 
has higher ability so that it favors the extended conformation. In contrast, Ca2+ has lower 
ability so that it favors the bent conformation. 
 In the switchblade model, the leg separation can induce extension during inside-
out signaling. In order to test it, SMD simulations were run to separate legs. A big force 
peak was observed, showing the breakage of interactions between the legs (Fig. 6.16). 
This force peak is larger than that during the unbending, showing the interactions 
between the legs are stronger than those between the headpiece and the tailpiece. Indeed, 
the broken interactions involve extensive contacts at Calf2/βTD, Calf2/β-ankle, 
Calf2/EGF4, Calf1/EGF3, and Calf1/EGF2 interfaces (Fig. 6.17). After leg separation, 
the interactions between the headpiece and the tailpiece of β-subunit were mostly kept. 
Even more new interactions formed between Hybrid and EGF3 or between PSI and 
EGF2. As a result, the unbending with separated legs has two additional peaks (Fig. 6.19), 
indicating more resistance. This demonstrates that leg separation does not facilitate 
extension.  
The free MD simulations with separated legs showed that a fully extended 
conformation was not stable because the interactions that stabilized the extended 
conformation with closed legs were not observed in the case of separated legs (Fig. 6.24). 
Also, a partially extended conformation did not return to the bent conformation as what 
occurred with closed legs (Figs. 6.22 and 6.23). All these suggest that the interactions 
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between the legs stabilize both the extended and the bent conformations. With separated 
legs, the integrin probably favors a partially extended conformation.  
Experiments suggest that talin head alone bound to the cytoplasmic tail of 
integrins can activate integrins. From the simulations here, it is hard to imagine talin head 
binding would give enough energy to separate legs and extend integrins. Most likely, 
some smaller conformational changes occur as suggested by the deadbolt model [51] so 
that βA switches to an intermediate affinity state for ligand binding. After engagement of 
ligands and/or with force, the integrin can be unbent and the legs can be separated so that 
the integrin is brought into a high affinity state. 
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CHAPTER 8  
RECOMMENDATIONS FOR FUTURE WORK  
CD16-IgG Binding 
 The study in this thesis provides one structural mechanism for regulation of  the 
CD16-IgG binding by glycosylation and gives ideas about the general role of 
glycosylation on Ig-FcR interactions. Actually, the important role of glycosylation on 
antibodies has been recognized since 1980s [91]. The general interests and the success of 
the current project inspire further studies. 
 Residue Fucose of the carbohydrate chain on IgG Fc was shown to be important 
by MD simulations here or published experimental data [86]. It is worth to run MD 
simulations with the removal of the Fucose to see how the conformation and the binding 
will be changed.  
 Over 30 glycoforms have been identified for attached glycans on IgG. Individual 
glycoforms of IgG may contribute to modulating inflammatory responses. Kaneko et al. 
[92] showed that even the change of a sugar residue far away from the binding pocket can 
change the IgG-FcR binding and following effector functions. So it is of interests to look 
at the effects of those sugar residues on the IgG-FcR binding by molecular simulations 
and understand the structural mechanism. 
 CD16 conformational changes were observed during MD simulations. The 
conformational changes may affect the CD16-IgG binding. With different anchors, CD16 
may favor different conformations or amplify the observed conformational changes, 
resulting in changes of the binding affinity. To test this hypothesis, MD simulations for 
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CD16 with anchors need to be performed to see how the conformations and dynamics of 
CD16 and the CD16-IgG binding will be affected. 
VWF A Domains 
 In this study, the VWF A1 and A2 domains were unfolded in simulations either 
by a force or under high temperature. The observed unfolding pathways provide 
structural basis for understanding their stabilities and offer insights into the way 
ADAMTS-13 interacts with and cleaves the A2 domains. Based on current study, further 
research could be pursued as follows. 
 Does a stable intermediate state exist during the unfolding of A2? If yes, this 
intermediate state could imply how ADAMTS-13 accesses the cleavage site and cuts it. 
Constant-force SMD with relatively small force should be used to detect the intermediate 
because the intermediates are expected to last longer under smaller force. 
 An A2/ADAMTS-13 complex structure is needed for understanding the 
mechanism of VWF cleavage by ADAMTS-13. Currently, no ADAMTS-13 crystal 
structure is available. But the crystal structures of several homologous ADAMTS family 
members, including ADAMTS-1, 4, and 5, are available [87-89]. So the homology model 
of ADAMTS-13 can be made. Combined with the unfolding structures of A2, a 
homology model of A2/ADAMTS-13 complex can be obtained. The homology model 
could reveal important interactions between A2 and ADAMTS-13 and shed light on the 
mechanism of VWF cleavage by ADAMTS-13. 
 Most mutations associated with type 2A VWD locate at the A2 domain [31, 32]. 
These mutations may affect unfolding of the A2 domain, its interactions with other VWF 
domains, and/or its interactions with ADAMTS-13. Sutherland et al. [25] showed that 
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some of the type 2A VWD mutations caused some structural changes of the A2 domain 
with equilibration at 310 K. Do these mutations affect the resistance of the A2 domain to 
unfolding or change the unfolding pathway? Future unfolding simulations with these 
mutations should be performed. 
Integrin Global Conformational Changes 
 In this thesis, the transition of integrin conformations from the bent to the 
extended was successfully simulated. The study provides the structural basis for 
understanding the mechanism of integrin functions.  
At the time of preparation of this thesis, a new crystal structure of αIIbβ3 just came 
out [46]. Probably more crystal structures of other integrins will be available in the near 
future. Because the unresolved domains of αVβ3 are visible in the new crystal structure of 
αIIbβ3, it is worth to run simulations with the new structure to justify what was obtained 
here, although it may not change the major conclusions since it only affects the 
interactions at β-genu.  
The variations of sequences across integrin family are big. The critical residues 
identified for αVβ3 are mostly not conserved among other integrins. It suggests that 
different integrins may have different stabilities of either the bent or the extended 
conformation, which may determine how hard integrins can be activated. Therefore, it is 
quite interesting to simulate conformational changes of different integrins. The 
comparison will give clues to understand the mechanism of integrin activation. 
Just before submission of the thesis, the structure of the transmembrane segments 
of αIIbβ3 integrin by nuclear magnetic resonance (NMR) was released [93]. So the 
structures of most parts of integrin are available now. With these structures, a complete 
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structure of the whole integrin can be obtained. Therefore, it is time to simulate the whole 
integrin anchored in a lipid bilayer, mimicking the membrane environment. With this 
system, the pathway of signal transduction between the cytoplasmic tails and the ligand 
binding head can be studied. It sounds like a daunting task because the system will be 
even larger than that was simulated here. The real problem is that the time scale can be 
reached is only 10 ns order, in which the interesting signal propagation is hardly seen. A 
coarse-grain model may be more suitable for simulating the system. The coarse-grain 
model can simulate the propagation of structural changes through multiple domains, 
while all-atom simulations are still needed to identify important interactions and study 
subtle changes in the binding pocket. Combination of these two types of simulations is a 
promising method to reveal the structural mechanism of integrin functions. 
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